Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 21, 2026.

Chemical Composition and Biological Activities of Essential Oils of Curcuma Species

Noura S. Dosoky, William N. Setzer

Nutrients · 2018 · Review · CC BY

doi:10.3390/nu10091196

Abstract

Members of the genus Curcuma L. have been used in traditional medicine for centuries for treating gastrointestinal disorders, pain, inflammatory conditions, wounds, and for cancer prevention and antiaging, among others. Many of the biological activities of Curcuma species can be attributed to nonvolatile curcuminoids, but these plants also produce volatile chemicals. Essential oils, in general, have shown numerous beneficial effects for health maintenance and treatment of diseases. Essential oils from Curcuma spp., particularly C. longa, have demonstrated various health-related biological activities and several essential oil companies have recently marketed Curcuma oils. This review summarizes the volatile components of various Curcuma species, the biological activities of Curcuma essential oils, and potential safety concerns of Curcuma essential oils and their components.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Introduction

The genus Curcuma L. (Zingiberaceae) represents a group of perennial rhizomatous herbs native to tropical and subtropical regions. Curcuma is extensively cultivated in tropical and subtropical regions of Asia, Australia, and South America. There are approximately 93–100 accepted Curcuma species, however the exact number of species is still controversial. The genus is best known for being an essential source of coloring and flavoring agents in the Asian cuisines, traditional medicines, spices, dyes, perfumes, cosmetics, and ornamental plants. Several Curcuma species are used medicinally in Bangladesh, Malaysia, India, Nepal, and Thailand for treating pneumonia, bronchial complaints, leucorrhea, diarrhea, dysentery, infectious wounds or abscesses, and insect bites. The rhizome is the most commonly used part of the plant. The main active components of the rhizome are the nonvolatile curcuminoids and the volatile oil. Curcuminoids (curcumin, demethoxycurcumin, and bisdemethoxycurcumin) are nontoxic polyphenolic derivatives of curcumin that exert a wide range of biological activities. Several phytochemical studies on Curcuma oils led to the identification of sesquiterpenoids and monoterpenoids as the major components. The essential oil (EO) of Curcuma species possesses a wide variety of pharmacological properties, including anti-inflammatory, anticancerous, antiproliferative, hypocholesterolemic, antidiabetic, antihepatotoxic, antidiarrheal, carminative, diuretic, antirheumatic, hypotensive, antioxidant, antimicrobial, antiviral, insecticidal, larvicidal, antivenomous, antithrombotic, antityrosinase, and cyclooxygenase-1 (COX-1) inhibitory activities, among others. Curcuma oils are also known to enhance immune function, promote blood circulation, accelerate toxin elimination, and stimulate digestion. C. longa (turmeric) and C. zedoaria (zedoary) are the most extensively studied species of Curcuma due to their high commercial value. Other Curcuma species have been studied to a lesser degree. This review provides an update on recent studies performed on the chemical composition and biological studies on genus Curcuma. The search engines Google Scholar, PubMed, ScienceDirect, and ResearchGate were used to access the literature.

2. Volatile Components of Curcuma spp.

Generally, essential oils of Curcuma species are obtained by hydro- or steam distillation of the fresh or dry rhizome. Alternatively, Curcuma volatiles have also been obtained by solvent extraction or supercritical fluid extraction of the powdered rhizome. More recently, solid-phase microextraction (SPME) has been employed as a solvent-free technique to capture and concentrate volatiles from different plant parts. Industrially, Curcuma oil is produced during oleoresin processing as a byproduct of curcumin extraction. After curcumin is isolated from the oleoresin, the mother liquor (about 70–80%) is known as “curcumin-removed turmeric oleoresin” (CRTO). The oil is then extracted from CRTO by hexane or other organic solvent, a process that could result in the loss of the highly volatile components during solvent evaporation. The use of alcohols as the solvent for oil extraction might cause esterification, etherification, and acetal formation. The volatile components of different Curcuma species, typically identified by gas chromatography mass spectrometry, are summarized in Table 1. In general, Curcuma species produce a wide variety of volatile sesquiterpenes, monoterpenes, and other aromatic compounds. The chemical structures of key volatile components are presented in Figure 1. There is a tremendous variation in the composition of Curcuma essential oils (EOs). Differences in the oil chemical profile might be due to genotype, variety, differential geography, climate, season, cultivation practices, fertilizer application, stress during growth or maturity, harvesting time, stage of maturity, storage, extraction, and analysis methods. However, some of the variation could be due to misidentification of the plant species or some of the components.

2.1. Curcuma longa L.

Curcuma longa (syn. C. domestica Valeton and C. brog Valeton) is also known as “turmeric” worldwide, “kurkum” in Arabic, and “haldi” in Hindi and Urdu. Turmeric is cultivated extensively worldwide but is native to Southeast Asia. It is a perennial herb grown on a very large scale in India, Pakistan, Bangladesh, China, Taiwan, Thailand, Sri Lanka, East Indies, Burma, Indonesia, and Northern Australia. In the West, it is produced in Costa Rica, Haiti, Jamaica, Peru, and Brazil. Turmeric is commercially available as a whole rhizome (fresh, dried, and cured by cooking in water, drying in shade, and polishing), turmeric powder, extracts, and oleoresins, with the powder being the most commonly consumed form. India is the largest producer and consumer of turmeric. The plant is famous for its culinary and medicinal uses. Turmeric is the golden spice that gives many Asian dishes their yellow color and pungent earthy flavor. It is an essential ingredient of curry powders, accounting for about 10–30% of the blend. In traditional medicine, turmeric is extensively used as a carminative, digestive aid, stomachic, appetizer, anthelmintic, tonic and laxative. It is also used for treating fever, gastritis, dysentery, infections, chest congestion, cough, hypercholesterolemia, hypertension, rheumatoid arthritis, jaundice, liver and gall bladder problems, urinary tract infections, skin diseases, diabetic wounds, and menstrual discomfort. Turmeric is used in many religious rituals, as a dye, and as a cosmetic. Turmeric rhizome typically contains carbohydrates (69.4%), protein (6.3%), fat (5.1%), and minerals (3.5%).

Turmeric oleoresin is an orange-red viscous liquid, prepared from the powdered rhizome by solvent extraction with a yield of about 12%. The main active components in the rhizome are essential oil and curcuminoids. The volatile oil is responsible for the turmeric aroma, while the curcuminoids (curcumin and its analogues) are responsible for its bright yellow color. It is worth mentioning that curcumin, present in turmeric rhizomes, oleoresin, and CO2 extract, has not been reported in the essential oil. Turmeric chemotypes in the literature vary widely. Hundreds of compounds have been identified from the turmeric EO; however, the major constituents are ar-turmerone, α-turmerone, and β-turmerone, followed by notable amounts of α-zingiberene, curlone, ar-curcumene, α-santalene, santalenone, β-sesquiphellandrene, (Z)-β-ocimene, β-bisabolene, β-caryophyllene, α-phellandrene, (Z)-β-farnesene, humulene oxide, β-selinene, caryophyllene oxide, (E)-γ-atlantone, 1,8-cineole, and terpinolene. Samples from Brazil had (Z)-γ-atlantone, ar-turmerone, and (E)-γ-atlantone. A sample from north-central Nigeria was a mixture of β-bisabolene, (E)-β-ocimene, β-myrcene, 1,8-cineole, α-thujene, α-phellandrene, limonene, zingiberene, and β-sesquiphellandrene. Turmeric EOs from Sri Lanka and São Tomé and Principe had α-phellandrene, α-turmerone, 1,8-cineole, p-cymene, ar-turmerone, β-turmerone, and terpinolene as the main constituents. Some turmeric rhizome EOs from India contained 1,8-cineole, α-turmerone, β-caryophyllene, β-elemene, ar-turmerone, β-sesquiphellandrene, camphor, α-farnesene, and (Z, Z)-farnesol. Wide variations are also found between the EO obtained from fresh and dry rhizomes. Unfortunately, comparative data on the chemical composition of volatile oil from fresh and dry rhizomes from a single source, single geographical location, and same season are scarce. However, some of the variation could be explained by the rhizome processing. The order of yield is cured > fresh > dried rhizome. Some of the highly volatile low-boiling-point compounds might be lost during rhizome processing that involves grating, heating, drying, and grinding. For example, turmerones are major components in fresh rhizomes, while only minor ones in dry rhizomes, which might be due to oxidation/polymerization of the two conjugated double bonds.

Turmeric root EO from Kerala, India contained ar-turmerone (46.8%) and ar-curcumene (7.0%) as the main components. There are seven different chemotypes of the C. longa leaf EO reported so far: (1) ar-turmerone-rich chemotype; (2) α-phellandrene-rich chemotype; (3) terpinolene-rich chemotype; (4) β-sesquiphellandrene-rich chemotype; (5) p-cymene-rich chemotype; (6) 1,8-cineole-rich chemotype; and (7) myrcene-rich chemotype. Turmeric flower EO from India contained p-cymen-8-ol (26.0%) and terpinolene (7.4%), while the floral oil from France had terpinolene (67.4%) as the main component.

2.2. Curcuma zedoaria (Christm.) Roscoe

Curcuma zedoaria (syn. C. malabarica Velay, Amalraj and Mural; C. raktakanta Mangaly and M. Sabu) is commonly known as “zedoary” and “white turmeric” in English and “er-jyur” in Chinese. It is native to northeast India and Indonesia, but widely cultivated in subtropical regions including India, Southeast Asia, Thailand, Indonesia, Japan, and China. Zedoary rhizome looks like ginger from the outside (wrinkled gray, ash-colored) and like turmeric from the inside (brownish red-yellow). It has a less intense aroma that can be rated between turmeric and mango. In addition, the rhizome powder of C. zedoaria is used for culinary purposes because of its unique smell, but has a very bitter and pungent taste, causing many people to substitute it with ginger. Different parts of C. zedoaria have been used for treating hematologic and circulation abnormalities, wounds, digestive problems, flatulence, skin diseases, and various infections. Zedoary rhizome extracts exhibit anticancer, anti-inflammatory, analgesic, antiallergic, antiparasitic against Entamoeba histolytica, antibacterial and antifungal activities. C. zedoaria rhizome oil is mainly composed of sesquiterpenoids (80–85%) and monoterpenoids (15–20%). The reported major components of C. zedoaria rhizome EO include epicurzerene (19.0–46.6%), curzerene (10.4%), curdione (7.0–19.6%),, curzerenone (22.3–31.6%), debromofiliforminol (31.5%), 1,8-cineole (18.5–40.8%), β-sesquiphellandrene (21.5%), p-cymene (18.4%), curcumenene (18.7%), and α-phellandrene (14.9%). α-Terpinyl acetate (8.4%), isoborneol (7.0%), dehydrocurdione (9.0%) and selina-4(15),7(11)-dien-8-one (9.4%) are the main components in the leaf oil.

2.3. Curcuma aeruginosa Roxb.

Curcuma aeruginosa is also known as “pink-and-blue ginger” or “black curcuma” in English, “temu hitam” in Malaysia, and “waan-maha-mek”, “kamindam”, or “kajeawdang” in Thailand. It is an aromatic perennial herb (30–40 cm high) that is thought to have been derived from Burma and spread to tropical countries like Malaysia, Thailand, India, and Indonesia. C. aeruginosa has a distinctive ginger-like odor. In folk medicine, C. aeruginosa rhizome is used for treating dyspepsia, gastritis, dysentery, flatulence, diarrhea, postpartum problems, and parasitic infections, as well as tumors, bronchitis, and asthma. C. aeruginosa EO is usually composed of relatively equal amounts of monoterpenes and sesquiterpenes. The rhizome EO of C. aeruginosa is mainly composed of 8,9-dehydro-9-formyl-cycloisolongifolene (35.3%), dihydrocostunolide (22.5%), germacrone (23.5%), curzerenone (11.8%), dehydrocurdione (27.6%), curcumenol (15.1%), 1,8-cineole (22.7%), germacrone (17.7%), camphor (29.4%), germacrone (21.2%), curcumenol (38.7%), and β-pinene (27.5%). The leaf oil is made of 1,8-cineole, curzerenone, furanogermenone, camphor, and furanodienone or curzerene, germacrone, 1,8-cineole, and camphor.

2.4. Curcuma zanthorrhiza Roxb.

Curcuma zanthorrhiza (Syn. C. xanthorrhiza), also known as “wan-salika-linthong” in Thailand, and “temulawak”, “Javanese ginger”, or “Javanese turmeric” in Indonesia, is native to Indonesia and the Malay Peninsula and is cultivated in Thailand, Philippines, Malaysia, and Sri Lanka. In Indonesia, C. zanthorrhiza rhizomes are utilized as food coloring, a spice, a source of starch, a dye, in cosmetics, and in traditional medicine. In traditional medicine, infusions and extracts of C. zanthorrhiza rhizome are used in treating hypertension, diabetes, constipation, fevers, diarrhea, dysentery, liver damage, gastric problems, rheumatism, haemorrhoids, skin eruptions, and some cancers. The fresh rhizome or dried powder of C. zanthorrhiza is used for skin diseases in northern Thailand. Generally, monoterpenes predominate (80–88%) the rhizome EO of C. zanthorrhiza. Three major chemotypes can be observed: (1) α-curcumene-dominated chemotype; (2) α-terpinolene-rich chemotype; and (3) xanthorrhizol-dominated chemotype. Xanthorrhizol accounts for 64.4% of the hydrodistilled oil from fresh C. zanthorrhiza rhizome from India, while only 8.0% of the oil obtained by supercritical carbon dioxide extraction. The hexane extract of C. zanthorrhiza gave α-curcumene, germacrone, and zederone, whereas the dichloromethane extract contains curcumin and xanthorrhizol.

2.5. Curcuma aromatica Salisb.

Curcuma aromatica (syn. C. wenyujin Y.H. Chen and C. Ling), commonly known as wild turmeric, is a perennial plant that grows in the tropical and subtropical regions. It is broadly cultivated in China, India, and Japan. It is used as a flavoring and coloring agent as well as a traditional medicine for eliminating blood stasis, slowing the aging process, alleviating pain, and protecting against liver diseases. C. aromatica is used to promote blood circulation and to fight various microbial infections. Internally, wild-turmeric rhizomes are used as a tonic and carminative, while externally they are applied for treating skin eruptions and infections, and to improve complexion, ease bruises, and relieve sprains and snake bites. It possesses anti-inflammatory, anticancer, antiangiogenic, antioxidative, and antimicrobial activities. It is known to produce antidepressant-like effects in chronic unpredictable stress-induced depression. The major constituents in C. aromatica rhizome EO contain 8,9-dehydro-9- formyl-cycloisolongifolene (2.7–36.8%), germacrone (4.3–16.5%), ar-turmerone (2.5–17.7%), turmerone (2.6–18.4%), curdione (50.6%), camphor (18.8–32.3%), xanthorrhizol (26.3%), ar-curcumene (19.5%), di-epi-α-cedrene (16.5%), curcumol (35.8%), and 1,8-cineole (12.2%). The leaf EO contains camphor (24.0%–28.5%) and p-cymene (25.2%) as the main components.

2.6. Curcuma phaeocaulis Valeton

Curcuma phaeocaulis is known as “pengezhu”, “ezhu” and “heihejianghuang” in Chinese. C. phaeocaulis is widely found throughout the southern parts of China. In Chinese medicine, the rhizome of C. phaeocaulis is one of the commonly prescribed herbs, and is known as Rhizoma Curcumae. Individually or in combination with other herbs, Rhizoma Curcumae is used in controlling gastritis, reducing blood stasis, and alleviating pain. The State Food and Drug Administration of China has already approved Rhizoma Curcumae oil as a therapeutic remedy for several disorders. Rhizoma Curcumae preparations and oils possess several pharmacological activities, including analgesic, hepatoprotective, antithrombic, antimicrobial, antiviral, and anti-inflammatory effects. C. phaeocaulis rhizome EO has 8,9-dehydro-9-formyl-cycloisolongifolene (15.6–46.2%), germacrone (8.9–21.2%), and curlone (0.8–20.2%) as the main constituents.

2.7. Curcuma amada Roxb.

Curcuma amada is a perennial herb native to East India. It is commonly known as the “mango ginger” and “manga manjal” because of its raw mango flavor that is mainly attributed to the presence of δ-3-carene, myrcene, and (Z)-β-ocimene. It is used in culinary preparations, medicines, and as a source of starch. In the Ayurveda and Unani medicinal systems, mango ginger is used as an appetizer, laxative, diuretic, antipyretic, aphrodisiac, emollient, and expectorant. It also helps in treating bronchitis, asthma, itching, inflammation, and skin diseases. A paste made from the rhizome is used externally to relieve bruises, sprains, contusions, and rheumatic pain. The rhizome EO of C. amada from India is dominated by myrcene. A totally different composition for the C. amada rhizome EO was reported by Mustafa et al., with (Z)-β-farnesene (21.9%), 6,9-guaiadiene (19.8%), α-longipinene (14.8%), and α-guaiene (14.5%), and camphor (5.5%) as the major constituents and thymol (4.9%) as the aromatic constituent contributing to the odor of the oil. Other reported compositions include (E)-hydroocimene, (Z)-hydroocimene, myrcene, and linalool, and ar-curcumene, β-curcumene, camphor, curzerenone, and 1,8-cineole. The leaf oil is made of camphor, epi-curzerenone, curzerenone, and isoborneol.

2.8. Curcuma caesia Roxb.

Curcuma caesia is commonly known as “black turmeric” in India due to the dark bluish color of its rhizome. It grows wild in some parts of India, Malaysia, Thailand, and Indonesia. Leaves and rhizomes of black turmeric are used in traditional medicine. C. caesia rhizome is aromatic, carminative, and a stimulant. A paste of the rhizome is used for treating dysentery and as poultice in rheumatic pain, sprains, and bruises. When applied externally, black turmeric is used in India to alleviate toothaches, treat skin and wound infections, and cure rheumatism. Chewing small amounts of the rhizomes is used to relieve digestive problems and kidney disorders; however, excessive intake of black turmeric may lead to vomiting. The rhizome EO of C. caesia from south India was composed mainly of 1,8-cineole (30.1%) followed by camphor, ar-curcumene, and camphene, while the oil from central India has camphor (28.3%), followed by ar-turmerone, (Z)-β-ocimene, ar-curcumene, and 1,8-cineole. The leaf EO is made of 1,8-cineole (27.0%) and camphor (16.8%).

2.9. Other Curcuma Species

Other Curcuma species have been investigated to a lesser degree, in part due to their limited commercial interest. Curcuma albiflora Thwaites rhizome EO contains α-pinene, caryophyllene oxide, and alconfor. C. alismatifolia Gagnep, commonly known as Siam tulip, is an ornamental plant.-Xanthorrhizol (52.4%) and ar-curcumene (27.4%) dominate the root EO, while β-curcumene (42.0%),-xanthorrhixol (36.6%), and α-curcumene (7.5%) are the major components of the rhizome EO. C. angustifolia Roxb. rhizome is used in folk medicine to treat asthma, dysentery, fungal infections, fevers, as well as an analgesic, antiparasitic, and muscle relaxant. The EO obtained from C. angustifolia root is dominated by β-elemenone (65.0%), while the rhizome EO has three chemotypes so far: (1) xanthorrhizol isomer- methyleugenol-rich chemotype; (2) germacrone and camphor-rich chemotype; and (3) curzerenone-dominated chemotype as the main components. In the fresh rhizome EO of C. aurantiaca Zijp, piperitenone accounts for 65.2%. Another sample of C. aurantiaca EO from India was made of 1,8-cineole, camphor, germacrone, β-elemene, curzerene, and β-elemenone. C. elata Roxb. rhizome EO from China is mainly made of 8,9-dehydro-9-formyl- cycloisolongifolene (52.2%), followed by germacrone (14.0%). The rhizome of C. glans K. Larsen and J. Mood has been traditionally used in treating tonsillitis, sore throat, wounds or abscesses in the mouth, throat, and nose, as well as the herpes simplex virus. Sesquiterpenes (50.10%) dominates the EO of C. glans rhizome. The Thai oil of C. glans rhizome is dominated by germacrone, camphor, β-pinene, and 2-nonanol. The rhizome oil of C. haritha Mangaly and M. Sabu contains camphor, 1,8-cineole, isoborneol, curdione and camphene as the main constituents. Germacrone is the main component in the rhizome EO of C. harmadii Gagnep and C. leucorhiza Roxb.. C. harmadii EO from Vietnam has 1,8-cineole, germacrone, β-pinene, β-elemene, and isocurcumenol. The major constituents of C. inodora Blatt rhizome EO are curzerenone, germacrone, curdione, and 1,8-cineole. The oil obtained from C. kwangsiensis S.G. Lee and C.F. Liang fresh rhizome was made of α-elemene, germacrene D, spathulenol, curdinone, and β-bisabolene. The major volatile components of C. kwangsiensis from Guangxi, China include germacrone, β-elemenone, β-elemene, curzerenone, and curdione.

Curcuma mangga Valeton and Zijp. rhizome EO was reported to have two chemotypes, (1) caryophyllene oxide and caryophyllene-rich chemotype, and myrcene-dominated chemotype. The major components of C. nankunshanensis N. Liu, X.B. Ye and Juan Chen fresh rhizome EO from China were curdione, germacrone, 8,9-dehydro-9-formyl-cycloisolongifolene, and velleral. Caryophyllene, phytol, humulene, elemene, and caryophyllene oxide were detected as major compounds in the EO of the C. oligantha Trimen rhizome. C. pseudomontana J. Graham rhizome EO from India was made of β-elemenone, pseudocumenol, germacrone, 2-(4-methoxyphenyl) N, N-trimethyl-1-pyrrolamine, and (1,5-dimethyl-4-hexenyl)-4-methylbenzene. The powdered rhizome of C. purpurascens Blume, also known as “temu tis” in Indonesia, is taken in combination with other herbs to treat cough and skin infections. The EO of C. purpurascens rhizome contains turmerone as the major constituent, followed by germacrone, ar-turmerone, germacrene B, curlone, and curzerene. C. rhabdota Sirirugsa and M.F. Newman contains germacrone, butyl butanoate, sec-butyl butanoate, camphene, and germacrene B as the main constituents. C. rubescens Roxb. rhizome EO from China was composed of zerumbone, ar-turmerone, germacrone, camphor, and aromadendrene oxide. C. sichuanensis X.X. Chen rhizome EO from China was made of germacrone followed by β-elemenone and isoaromadendrene epoxide. Samples from Sichuan, China showed two more different compositions. C. singularis Gagnep. fresh rhizome EO contained camphor and germacrone. C. sylvatica Valeton rhizome oil from India was dominated by α-fenchene. C. trichosantha Gagnep EO was mainly made of curdione. C. yunnanensis N. Liu and S.J. Chen rhizome EO from China was composed of germacrone, 8,9-dehydro-9-formyl-cycloisolongifolene, dihydrocostunolide, β-farnesene, and aromadendrene oxide. To the best of our knowledge, there are no published studies on the other Curcuma species.

3. Biological Activities of Curcuma Oils

Members of Zingiberaceae are known for containing terpenoids, flavonoids, phenypropanoids and sesquiterpenes, which have antitumor activities. Some Curcuma essential oils have remarkable antioxidant and antimicrobial activities that make them ideal candidates for use in pharmaceutical and cosmetic industries. The variations in chemical composition imply the possibility of different biological activities of the same plant species from different locations. A summary of the biological activities of different Curcuma essential oils is presented in Table 2.

3.1. Turmeric (C. longa) Essential Oil

Turmeric EO has the potential to provide protection against cardiovascular diseases. The oil was reported to have antihyperlipidemic effects on high-fat diet (HFD)-induced hyperlipidemia in rats. It markedly decreased the levels of triglycerides, free fatty acids, total cholesterol in serum, and low-density lipoprotein (LDL) cholesterol, while increasing the level of high-density lipoprotein (HDL) cholesterol. Turmeric EO also showed antihyperlipidemic effects in hyperlipidemic golden Syrian hamsters via reducing lipid-induced oxidative stress, platelet activation, and vascular dysfunction. Chronic dietary supplementation of turmeric EO (≥620 mg/kg/day) showed antidiabetic and hypoglycemic effects in diabetic mice by normalizing serum glucose. Ingestion of turmeric oleoresin and essential oil inhibited both the increase in blood glucose and the development of abdominal fat mass in obese diabetic rats. Turmeric EO also inhibited α-glucosidase and α-amylase activities in a dose-dependent manner due to the presence of ar-turmerone.

In addition, the oil showed remarkable antioxidant activity as judged by 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity assay, ferric reducing/antioxidant power (FRAP) assay, superoxide anion radical scavenging activity assay, and metal-chelating activity assay. Turmeric EO prevented oxidative stress in Brycon amazonicus via reducing the synthesis or release of cortisol and increasing the activity of antioxidant enzymes, and thereby protecting from the formation of reactive oxygen species excess. The potent antioxidant activity of turmeric EO is thought to be responsible for inhibiting brain-edema formation, one of the most dangerous consequences of ischemic brain injury. Treatment with turmeric EO reduced nitric oxide production derived by inducible nitric oxide synthase (iNOS) during ischemic injury. Turmeric EO inhibited copper-mediated oxidation of LDL in the thiobarbituric acid reactive substances assay (IC50 = 7.8 ± 0.2 µg/mL). Turmeric EO (250–500 mg/kg p.o. or i.p.) showed neuroprotective effects in rat embolic-stroke model. In filament model of middle cerebral-artery occlusion, pretreatment with turmeric EO showed a neuroprotective effect by inhibiting the generation of free radicals. Its neuroprotective efficacy was mediated by reducing endothelial cell-mediated inflammation in postmyocardial ischemia/reperfusion in rats. It was also suggested that the ability of the oil to access the brain after stroke was via the transcellular lipophilic pathway. Turmeric EO (500 mg/kg, p.o.) was an efficacious and safe antiplatelet agent and was protective against intravascular thrombosis in myocardial ischemia-reperfusion and thrombosis rat models. Turmeric oil was effective in treating some respiratory disorders by preventing asthma, removing sputum, and relieving cough. The oil was reported to have anticancer and anti-inflammatory effects. It was active against human mouth epidermal carcinoma (KB) cells and mouse leukemia (P388) cells, with respective IC50 values of 1.088 and 0.084 mg/mL. It was also cytotoxic to the pancreatic cancer (PANC-1), melanoma (B16), prostate cancer (LNCaP), and human cervical adenocarcinoma (HeLa) cell lines due to the presence of ar-turmerone, α-turmerone, β-turmerone, curlone, ar-curcumene, zingiberene, and β-sesquiphellandrene. Crude organic extracts of turmeric-inhibited lipopolysaccharide (LPS)-induced production of tumor necrosis factor (TNF)-α (IC50 = 15.2 μg/mL) and prostaglandin E2 (PGE2; IC50 = 0.92μg/mL) in human leukemia (HL-60) cells. In combination with curcumin, turmerones from turmeric EO abolished inflammation-associated mouse-colon carcinogenesis. Turmeric EO demonstrated strong protective effect against benzo[a]pyrene-induced increase in micronuclei in circulating lymphocytes and protected against cytogenetic damage in patients suffering from oral submucous fibrosis, a precancerous condition for oral cancer.

Moreover, turmeric EO showed potent antiarthritic and joint protective effects on an animal model of rheumatoid arthritis. As a result of treatment with crude or refined turmeric oil (i.p.), joint swelling was dramatically inhibited (90–100% inhibition) in female rats with streptococcal cell wall-induced arthritis. Turmeric EO was reported to have antihepatotoxic, antiatherosclerotic, hypothermic, anxiolytic, sedative, anticonvulsant, and spasmolytic activities. Turmeric EO protected against accelerated atherosclerosis, inflammation, and macrophage foam-cell formation induced by arterial injury through modulating the genes involved in plaque stability, lipid homeostasis, and inflammation. Turmeric EO (200 mg/kg) exhibited antifatty liver and hepatoprotective activities in acute ethanol-induced fatty liver in rats through decreasing the activities of serum enzymes and levels of serum triglyceride, serum total cholesterol, and hepatic malondialdehyde, while restoring the level of reduced glutathione as well as the activities of glutathione-S-transferase and superoxide dismutase. The oil was markedly antimutagenic against sodium azide in the Ames test. Turmeric oil showed remarkable sedative and anesthetic effects in mice and fish in different experimental protocols. Interestingly, ar-turmerone isolated from turmeric EO is a potent antivenom against snakebites. It neutralized both the hemorrhagic activity present in Bothrops jararaca venom, and the lethal effect of Crotalus durissus venom in mice.

Additionally, turmeric EO showed potent antibacterial activity against Helicobacter pylori, Bacillus cereus, B. coagulans, B. subtilis, Staphylococcus aureus, Escherichia coli, Vibrio parahaemolyticus, Proteus mirabilis, and Pseudomonas aeruginosa. It also showed strong antifungal effects against Aspergillus flavus, A. niger, A. parasiticum, Rhizoctonia solani, Helminthosporium oryzae, Trichoconis padwickii, Curvularia lunata, C. pallescens, C. trifolii, Fusarium verticillioides, F. moniliforme, F. oxysporum, Penicillium digitatum, Alternaria dianthi, Trichophyton longifusus, and Colletotrichum falcatum. In addition, C. longa EO was reported to have antiaflatoxigenic activities. Turmeric EO exhibited insecticidal activity against the white termite (Odontotermes obesus) as well as insect-repellent activities. It showed repellency against both day- and night-biting mosquitoes. Turmeric oil and ar-turmerone isolated from the oil displayed mosquitocidal activity against Aedes aegypti larvae (LD100 = 50 µg/mL) and Anopheles quadrimaculatus. Moreover, turmeric EO inhibited the germination and growth of Avena fatua L., Echinochloa crus-galli (L.) Beauv, Allium cepa L., and Phalaris minor Retz. Turmeric-leaf EO showed cytotoxic activity against breast-tumor (Hs578T) and prostate-tumor (PC-3) cells. It also showed antibacterial, antifungal, antiaflatoxigenic, and mosquitocidal activities.

3.2. Zedoary (C. zedoaria) Essential Oil

Curcuma zedoaria EO showed potent radical-scavenging effects evaluated by DPPH assay. The strong antioxidant activity of C. zedoaria EO is utilized in the food industry to minimize or prevent lipid oxidation. Zedoary EO also showed potent, selective cytotoxic activity and inhibited the proliferation of human cervical cancer (SiHa), colorectal cancer (SNU-1), human hepatoma (HepG2), human gastric adenocarcinoma (AGS), hepatic stellate cells, mouse melanoma (B16BL6) cells, human hepatoma (SMMC-7721) cells, and HL-60 cells. It is worth noting that normal endothelial cells were less sensitive to zedoary EO than cancer cells in the in vitro assays. The cytotoxic activity of zedoary EO is mediated by efficiently inhibiting monocytic differentiation, inhibiting cell proliferation, arresting cell cycle and inducing apoptosis. The oil exhibited efficient cytotoxic effects against nonsmall cell lung carcinoma (NSCLC) cells via inducing apoptosis. Zedoary EO showed antiproliferative activity against human colon-cancer cells (HCT116) by causing senescence and apoptosis in a dose- and time-dependent manner. Zedoary EO in a combination with paclitaxel synergistically enhanced their antitumor activity and increased the apoptosis of human ovarian cancer (SKOV3) cells. Zedoary EO (i.p.) significantly inhibited the growth of human lung-cancer cells (H1299) in vivo via inhibiting protein kinase B (Akt)/nuclear factor-kappa B (NF-κB) signaling pathways. Zedoary EO was reported to inhibit angiogenesis in vitro and in vivo, which results in tumor inhibition. Zedoary EO strongly inhibits vascular endothelial growth factor (VEGF)-induced angiogenesis in vitro and tumor angiogenesis in vivo via downregulating matrix metalloproteinases. In rodent experiments, zedoary oil showed antitumor action in hepatoma-transplanted rats. In addition, it has been used clinically in China for treating hepatic carcinoma. In China, zedoary oil is used for treating gynecologic inflammation, monilial vaginitis, and tumors. Zedoary EO is also known for its hypoglycemic effects. In a study performed on streptozotocin-induced hyperglycemic Wistar rats, oral administration of the oil for seven days was able to significantly decrease blood-glucose levels and prevent gingivitis. Zedoary EO has been used for oral-health maintenance because of its antimicrobial, hypoglycemic, and anti-inflammatory properties, which can help in reducing gingival inflammation. Zedoary EO exhibited antimicrobial activity against Vibrio parahaemolyticus, Staphylococcus aureus, Bacillus cereus, Salmonella typhimurium, and Pseudomonas aeruginosa. It also demonstrated antifungal activity against Colletotrichum falcatum and good insecticidal activity against the sugarcane pest, Odontotermes obesus Rhamb. Zedoary oil displayed larvicidal effects against the malaria vector, Anopheles dirus (LC50 = 29.69 ppm), and the hemorrhagic fever vector, Aedes aegypti (LC50 = 31.87 ppm).

3.3. Curcuma aeruginosa Essential Oil

Curcuma aeruginosa EO showed antiandrogenic, antinociceptive, antipyretic, and anti-inflammatory activities. Topical application of C. aeruginosa extract (5% w/w) stimulated hair regrowth on patients with androgenic alopecia. In a randomized controlled trial, C. aeruginosa rhizome extract promoted hair regrowth in bald males. The bioactive compounds were identified as sesquiterpenes, with germacrone being the most potent. Coapplication of C. aeruginosa EO, hexane extract, and germacrone improved the skin penetration of minoxidil, a hair-growth promoter approved as topical treatment of androgenic alopecia. Skin penetration of minoxidil with EO, hexane extract, and germacrone was enhanced 20-fold, 4-fold, and 10-fold, respectively. In a randomized, double-blinded trial, C. aeruginosa rhizome EO formulated as a lotion (1% and 5% w/w EO) was reported to safely and effectively slow the growth of axillary hair and to rapidly and robustly increase axillary skin brightness (within three weeks). Interestingly, these effects persisted for two weeks after ending the treatment. The rhizome EO of C. aeruginosa showed potent antibacterial activity against Enterococcus faecalis (MIC = 6.25 µg/mL) and Streptococcus mutans (MIC = 15.63 µg/mL) and as a teeth-biofilm degradation, which makes it a good candidate as a natural antibacterial agent in a mouthwash or a toothpaste. It exhibited moderate antibacterial activity against Staphylococcus aureus (MIC = 125 µg/mL) and Bacillus cereus (MIC = 125 µg/mL). The oil showed antifungal activity against Candida albicans (MIC = 250 µg/mL). The oil showed weak inhibitory effect against Mycobacterium tuberculosis strain H37Ra (MIC = 2500 µg/mL) when tested by green fluorescent protein microplate assay. The oil also showed strong radical-scavenging power evaluated by DPPH scavenging assay (EC50 = 24.32 µg/mL) due to the presence of germacrone and curzerenone.

3.4. Curcuma zanthorrhiza Essential Oil

Curcuma zanthorrhiza EO possesses antiproliferative, anti-inflammatory, antidiuretic, hypotensive, antihepatotoxic, antioxidant, antibacterial, and antifungal activities. The anti-inflammatory activity of C. zanthorrhiza mainly depends on its germacrone content. The oil effectively inhibited copper-mediated oxidation of LDL in thiobarbituric acid reactive substances assay (IC50 = 2.2 ± 0.1 µg/mL). The rhizome EO of C. zanthorrhiza showed antibacterial activity against Staphylococcus aureus (ZOI = 11.53 ± 0.27 mm) and antifungal activity against Candida albicans (ZOI = 7.29 ± 0.17 mm). Wicaksono et al. reported analgesic effects (both central and peripheral) for C. zanthorrhiza EO, curcuminoid, and a combination of both in mice using the formalin test. Addition of C. zanthorrhiza EO (0.2%) or hexane-soluble fraction (0.5%) to rats' diet resulted in lower liver-triglyceride level and lower hepatic fatty-acid synthase activity. C. zanthorrhiza hexane-soluble fraction also caused a decrease in food intake and an increase in relative liver weight in rats, while the oil did not. C. zanthorrhiza had hypoglycemic activity and hypotriglyceridemic activity in diabetic rats, which was attributed to the activity of α-curcumene. The hexane extract of C. zanthorrhiza exhibited antioxidant, larvicidal, cytotoxic, and antimicrobial activities.

3.5. Wild Turmeric (Curcuma aromatica) Essential Oil

Wild turmeric EO is reported to promote blood circulation, remove blood stasis, and treat cancers. C. aromatica EO showed a remarkable anti-inflammatory activity via suppressing the production of proinflammatory cytokines including protein kinase C (PKC), Akt, tumor-necrosis factor-α (TNF-α), cyclooxygenase-2 (COX-2), NF-κB, and IκB kinase (IKK) in vivo in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced edema model. It is thought that turmerone, ar-turmerone, 8,9-dehydro-9-formyl-cycloisolongifolene, ar-curcumene, α-zingiberene, and germacrone are responsible for the anti-inflammatory activity of C. aromatica EO. The oil showed good cytotoxic activities against LNCaP HepG2, and B16 cell lines. The oil can also suppress the growth of hepatoma cells in vivo and in vitro. The oil was reported to induce apoptosis in NSCLC cells. ar-Tumerone, turmerone, and curdione from C. aromatica EO have in vitro and in vivo antiproliferative effect on laryngeal cancer (Hep-2) cells. Wild turmeric oil infused via hepatic artery inhibited hepatic tumors in patients with primary liver cancer, rats with transplanted hepatoma, and mice. C. aromatica EO showed antiproliferative effects on hepatoma by inhibiting its growth in mice (51–52%) via decreasing the DNA synthesis of hepatocellular carcinoma and shrinking the nucleus area. The antitumor activity of wild turmeric EO was attributed to the presence of β-elemene, curcumol, and curdione. C. aromatica EO showed hepatic chemopreventive activity against hepatocellular carcinoma both in vivo and in vitro. Pretreatment with C. aromatica oil (100 mg/kg for 3 days) protected mice from hepatic injury from inflammation and oxidative damage induced by concanavalin A, which can decrease the incidence of hepatocellular carcinoma.

Moreover, C. aromatica oil treatment (100 mg/kg, 200 mg/kg, 300 mg/kg body weight, i.p.) showed protective and antifibrosis activities in renal interstitial fibrosis rats in a time-dependent manner. Its mechanism involved inhibiting some metabolic pathways, including glycolysis, lipids metabolism, and methylamine metabolism. C. aromatica EO showed potent radical-scavenging activities in the DPPH radical scavenging assay (IC50 = 1.57–21.36 µg/mL), 2,2’-azinodi (3-ethyl benz-thiazoline sulfonic acid) diammonium salt (ABTS) radical scavenging assay, and β-carotene bleaching tests in a concentration-dependent manner due to the presence of 8,9-dehydro-9-formyl-cycloisolongifolene, germacrone, camphor, and borneol. Because of its potent antioxidant activity, wild turmeric EO inhibited the development of esophageal cancer when administered intraperitoneally to rats. In China, direct infusion of C. aromatica EO into the hepatic artery has been used in the clinical treatment of liver cancers. Curdione from C. aromatica EO exhibited antiplatelet aggregation and antithrombotic activities both in vitro and in vivo in a concentration-dependent manner. The oil also showed significant antibacterial activity against Staphylococcus aureus, Listeria monocytogenes, Bacillus subtilis, Pseudomonas aeruginosa, Salmonella typhimurium, and Escherichia coli, as well as antifungal activity against Candida albicans and Saccharomyces cerevisiae. In pediatrics, the oil is used for treating acute upper-respiratory infections, viral myocarditis, and acute pneumonia. C. aromatica EO also showed insecticidal effects against the booklouse Liposcelis bostrychophila Badonnel. The rhizome volatile oil and hexane crude extract of C. aromatica showed larvicidal, adulticidal, and repellent activities against the hemorrhagic fever vector, Aedes aegypti, with the oil being more potent. Hexane, dichloromethane, and methanol extracts of C. aromatica showed cardioprotective effects against isoproterenol-induced acute myocardial ischemia in rats. Moreover, the extracts also showed antidiabetic activity via antiglycation and inhibiting α-amylase. The leaf EO of C. aromatica showed antifungal activity against Colletotrichum falcatum and good insecticidal activity against the sugarcane pest, Odontotermes obesus Rhamb

3.6. Curcuma phaeocaulis Essential Oil

Curcuma phaeocaulis EOs and extracts have been reported to possess strong antimicrobial and antifungal activities. C. phaeocaulis EO showed moderate–strong antifungal activities against Candida albicans and Saccharomyces cerevisiae, and moderate–strong antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. These activities are thought to be due to the presence of germacrone, eremanthin, ar-curcumene, α-caryophyllene, and 8,9-dehydro-9-formyl-cycloisolongifolene. The oil also showed strong radical-scavenging activities evaluated by DPPH assay (IC50 = 2.17–22.36 µg/mL) due to the high 8,9-dehydro-9-formyl-cycloisolongifolene, curzerene, 1,8-cineole, and germacrone content. In addition, C. phaeocaulis EO exhibited a good anti-inflammatory activity through downregulating TNF-α and COX-2 expression in a TPA-induced skin-inflammation model. Most the C. phaeocaulis oils tested from China showed strong cytotoxic activities against LNCaP and B16 cell lines (IC50 = 20.36–79.44 µg/mL) due to the presence of 8,9-dehydro-9-formyl-cycloisolongifolene, while some samples from a different region in China showed weak cytotoxic activity (IC50 = 245.19–245.30 µg/mL).

3.7. Curcuma amada Essential Oil

Mango ginger possess central nervous system depressant, analgesic, antioxidant, anti-inflammatory, antiplatelet, cytotoxic, hypotriglyceridemic, antibacterial, and antifungal activities. C. amada rhizome EO and ethanolic extracts showed hepatoprotective effects against carbon tetrachloride-induced hepatotoxicity in male Wister rats mainly due to their strong antioxidant activities. The supercritical CO2 extract of mango ginger was selectively cytotoxic to human glioblastoma cell line (U-87MG; IC50 = 4.92 µg/mL). The extract was able to induce apoptosis in brain-tumor cells in a dose-dependent manner. The supercritical CO2 extract also exhibited antitumor effects in human glioblastoma multiforme cells both in vitro and in nude mice xenografts. It was synergistic with irinotecan, a chemotherapy drug. In fact, treatment with a combination of irinotecan and C. amada extract showed almost a complete inhibition of tumor growth. The extract was highly cytotoxic to human alveolar (SJRH30) and embryonal (RD) rhabdomyosarcoma cell lines, with IC50 values of 7.13 µg/mL and 7.50 µg/mL, respectively. It also showed synergistic cytotoxic effects with vinblastine and cyclophosphamide via inducing a higher percentage of apoptosis than individual agents. C. amada EO showed strong antioxidant activity as evaluated by DPPH radical scavenging assay, total antioxidant assay, ferric-reducing antioxidant power and nitric oxide scavenging assay. Moreover, C. amada EO showed 100% insect repellency and direct insecticidal effects against laboratory bred houseflies, Musca domestica L.. The oil was antibacterial against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella paratyphi, Vibrio cholera, Enterobacter aerogenes, Streptococcus pneumoniae, Bacillus subtilis, Bacillus cereus, Proteus mirabilis, Proteus vulgaris, and Serratia marcescens. Organic extracts of mango ginger also demonstrated antibacterial effects against E. coli, Bacillus subtilis, B. cereus, Staphylococcus aureus, Micrococcus luteus, Listeria monocytogenes, Enterococcus fecalis, and Salmonella typhi. C. amada EO showed antifungal activity against sugarcane pathogenic fungi such as Physalospora tucumanensis, Sclerotium rolfsii, Helminthosporium sacchari, and Cephalosporium sacchari.

3.8. Bioactivities of Other Curcuma Essential Oils

The EO of C. mangga showed strong antibacterial activities against Staphylococcus aureus (MIC = 1.2 µL/mL), Bacillus cereus (MIC = 11.1 µL/mL), P. aeruginosa (ZOI = 9.0 mm), and E. coli (ZOI = 7.0 mm), as well as antifungal activity against Candida albicans (MIC = 3.7 µL/mL) and Cryptococcus neoformans (MIC = 0.1 µL/mL). The rhizome EO of C. glans showed antibacterial activity against Staphylococcus aureus (ZOI = 17.24 ± 0.07 mm) and antifungal activity against C. albicans (ZOI = 7.27 ± 0.17 mm). C. singularis rhizome EO displayed moderate antibacterial activity against Bacillus subtillis (MIC = 100 µg/mL) and E. coli (MIC = 200 µg/mL). The rhizome and leaf EOs of C. angustifolia showed significant antioxidant activities with the leaf oil being more potent. The root and rhizome EOs of C. alismatifolia showed strong DPPH radical scavenging activity (EC50 = 10.2 ± 0.94 µg/mL and 11.48 ± 1.02 µg/mL, respectively) and ferric-reducing power activity (EC50 = 0.12 ± 0.03 µg/mL). C. elata EO showed a potent DPPH radical-scavenging activity and was cytotoxic to LNCaP (IC50 = 18.4 μg/mL) and HepG2 (IC50 = 167.75 μg/mL). C. sichuanensis EO and C. rubescens EO showed potent DPPH radical-scavenging activities (IC50 = 4.52 μg/mL and 22.32 μg/mL, respectively). C. sichuanensis oils (68.43% inhibition), C. nankunshanensis oils (55.23% inhibition), and C. elata oils (54.64% inhibition) exhibited a good anti-inflammatory effects in TPA-induced edema model. They inhibited the production of proinflammatory cytokines including PKC, Akt, TNF-α, COX-2, NF-κB, and IKK. The EO from C. kwangsiensis possesses antitumor, antioxidant, anti-inflammatory, bactericidal, antifungal, and antiviral activities. C. kwangsiensis, C. yunnanensis, C. nankunshanensis, C. sichuanensis, and C. rubescens EOs were cytotoxic to LNCaP (IC50 = 1.3–16.6 µg/mL), B16 (IC50 = 4.4–147.4 μg/mL), and HepG2 (IC50 = 153.1–198.2 µg/mL). C. purpurascens EO showed strong antiproliferative activity against human colorectal-cancer cells (HT-29; IC50 = 4.9 ± 0.4 μg/mL), and weak cytotoxicity against human lung-cancer (A549; IC50 = 46.3 ± 0.7 μg/mL), human cervical-cancer (Ca Ski; IC50 = 32.5 ± 1.1 μg/mL), and HCT116 cells (IC50 = 35.0 ± 0.3 μg/mL).

4. Toxicity and Safety

In general, Curcuma EOs are nontoxic, nonmutagenic, noncarcinogenic and nonphototoxic. Turmeric EO has been classified as generally recognized as safe (GRAS). Undiluted turmeric rhizome oil was slightly irritating to rabbits, but was not irritating to mice. When tested at 4% on 25 volunteers, it was neither irritating nor sensitizing. There is a possible drug interaction when used orally, especially with antidiabetic medications. The acute dermal LD50 of turmeric rhizome oil was >5 g/kg in rabbits, and the acute oral LD50 was >5 g/kg in rats. When administered intraperitoneally (i.p.) at doses higher than 28 mg/kg/day, 20–36% of normal and streptococcal cell wall-injected animals died after two weeks of treatment, while lower vehicle or oil doses (≤2.8 mg/kg/day) caused no deaths. Oral administration of a dose of turmeric oil that is 20-fold higher than the lowest effective i.p. doses was nontoxic. No hazards or adverse skin reactions were reported for turmeric-leaf EO; however, the α-phellandrene chemotype might cause skin sensitization on oxidation.

Zedoary EO has GRAS status. No acute toxicity or adverse reactions were reported for the zedoary oil; however, its consumption may interfere with gestation and may induce abortion. For this reason, the oil and extracts are strictly prohibited during pregnancy and should be avoided during breastfeeding. Zedoary EO showed obvious embryotoxicity ex vivo and reproductive toxicity in animal and developmental experiments. In addition, treatment with aqueous extracts of C. zedoaria rhizome (10 g/kg/day for 20 days) exhibited reproductive toxicity in pregnant mice. Chinese zedoary EO prevented implantation in dose-dependent manner. When given i.p. (300 mg/kg) to female rats on gestational days 7–9, it prevented 77% of pregnancies, and when administered intravaginally to female rabbits, it prevented 16% and 100% of pregnancies at 60 or 400 mg/kg/day on gestational days 5–9 and 2–4, respectively. It was suggested that the embryotoxic effect of zedoary EO might be caused by its sesquiterpenoids that can block VEGF-mediated angiogenesis. However, no direct evidence was found to link any of the oil components to its antifertility effect. Decoctions and ethanol extracts of zedoary rhizomes also have antifertility effects.

No hazards, acute toxicity, or adverse reactions were reported for the wild turmeric (C. aromatica), the mango ginger (C. amada), and the pink-and-black curcuma (C. aeruginosa) rhizome oils. No information found for the toxicity and safety of other Curcuma oils.

5. Bioactivity and Safety of Individual Key Components

A summary of the biological activities of key components of Curcuma essential oils is presented in Table 3.

ar-Turmerone, α-turmerone, and β-turmerone are major constituents of turmeric rhizome oil. ar-Turmerone displayed strong in vitro antiplatelet aggregation activity, antimutagenic, and potent hypoglycemic activity against α-glucosidase and α-amylase. ar-Turmerone effectively inhibited copper-mediated oxidation of LDL (IC50 = 2.2 ± 0.1 µg/mL). It also showed neuroprotective effect through inhibiting microglia activation, increasing neural-stem-cells proliferation, and promoting neuronal differentiation. ar-Turmerone, isolated from turmeric EO, showed potent cytotoxic activity against several cell lines including HL-60, human leukemia (K-562), rat leukemia (RBL-2H3), and mouse leukemia (L-1210), HeLa, HepG2, and human lymphoma (U937) via inducing apoptosis and internucleosomal DNA fragmentation. It was effective against sarcoma 180 ascites (connective tissue cancer) in mice at a dose of 50 mg/kg. ar-Turmerone is also a potent anti-inflammatory agent; it inhibits the production of inflammatory cytokines. ar-Turmerone exhibited a potent inhibition of both inducible COX-2 (IC50 = 5.2 µg/mL) and iNOS (IC50 = 3.2 µg/mL) as part of its cancer chemopreventive action. Turmerone-enriched turmeric oil protected from LPS-induced inflammation in human monocytes (THP-1), murine macrophages (J774.2), and Swiss mice. Turmerone isolated from C. longa showed antivenom and insect-repellent activities. It also had a strong antibacterial activity against Clostridium perfringens, and a strong antifungal activity against Aspergillus flavus. No acute toxicity was found for ar-tumerone, but it might be nontoxic, similar to turmeric rhizome oil. However, ar-turmerone has been classified as potential for allergic skin reaction (H317) and eye irritation (H319).

Curdione, the main component in C. aromatica, C. nankunshanensis, and C. trichosantha EOs significantly suppressed the proliferation of human breast-cancer cells (MCF-7) via inducing cell apoptosis and impairing mitochondrial-membrane potential. Curdione, from zedoary EO, inhibited PGE2 production in LPS-stimulated mouse macrophage RAW 264.7 cells (IC50 = 1.1 μM) through suppressing COX-2 expression. Curdione is also known for its outstanding antibacterial and antifungal activities. As far as we are aware, there are no known hazards associated with curdione.

1,8-Cineole possesses strong antioxidant and anticarcinogenic activities. The antioxidant activity of 1,8-cineole was associated with eliminating the 2,3,7,8-tetrachlorodibenzo- p-dioxin-induced oxidative stress in rats. 1,8-Cineole is not a skin irritant, convulsant, or photosensitizing. There is no evidence of carcinogenesis or teratogenesis in rodents. It is nonmutagenic, nongenotoxic, and nonfetotoxic in normal doses. High oral doses of cineole are toxic, especially to children. 1,8-Cineole neurotoxicity resulting from nasal instillation is expressed primarily as irritated mucous membranes, tachycardia, dyspnea, nausea, vomiting, vertigo, muscular weakness, drowsiness, and coma. The acute dermal LD50 of 1,8-Cineole was >5 g/kg in rabbits, while the acute oral LD50 was 2.48 g/kg in rats.

β-Caryophyllene is nontoxic, nonmutagenic and antitumor. It inhibited the growth of myelogenous leukemia cells (IC50 = 98.0mM; 20.4 μg/mL), HL-60 cells (IC50 = 19.31 μg/mL), human melanoma cells (IC50 = 20.10 μg/mL), and renal cell adenocarcinoma cells (IC50 = 21.81 μg/mL). It was moderately cytotoxic against human-breast and cervical cancer cell lines, and human and mouse melanoma cells. Survival was considerably increased after 4 daily intraperitoneal doses of 20 mg/kg β-caryophyllene in mice with ascites tumors. β-Caryophyllene showed antileishmanial activity against L. amazonensis amastigotes (IC50 = 1.3µg/mL), and antitrypanosomal activity against Trypanosoma cruzi epimastigotes (IC50 = 78.4µM), trypomastigotes, and amastigotes (IC50 = 63.7 µM). β-Caryophyllene is a weak skin allergen, and its oxidation does not increase its allergenicity. Undiluted β-caryophyllene was irritating to rabbit skin while when tested at 4%, it was neither irritating nor sensitizing on 25 volunteers. β-Caryophyllene induced allergic responses in 10 (0.6%) of 1,606 consecutive dermatitis patients when tested at 5%. When tested at 3%, oxidized β-caryophyllene (about 25% β-caryophyllene and 75% caryophyllene oxide) showed positive reaction in 8 (0.5%) of 1,511 consecutive dermatitis patients, one positive reaction in 21 dermatitis patients hypersensitive to fragrance materials, and none in 66 hand-eczema patients. β-Caryophyllene was not mutagenic in Salmonella typhimurium strains TA98 and TA100, and was antimutagenic in several assays. The acute oral LD50 of β-caryophyllene was >5 g/kg in rats, and the acute dermal LD50 was >5 g/kg in rabbits.

β-Myrcene possesses strong antimutagenic, chemopreventive, antiproliferative, and antioxidant effects. It is nonirritant, nonallergenic, nontoxic, and nongenotoxic. Undiluted β-myrcene was moderately irritating to rabbits, but was neither irritating nor sensitizing to 25 volunteers when tested at 4%. Oxidized myrcene (tested at 3% and containing 30% myrcene) showed reaction in only 0.07% in a multicenter study involving 1,511 consecutive dermatitis patients. The acute oral LD50 of β-myrcene was >5 g/kg in rats, and the acute dermal LD50 was >5 g/kg in rabbits. The oral “no observed adverse effect level” (NOAEL) of myrcene in rats was 300 mg/kg. Rodent studies suggest that β-myrcene might carry a risk of carcinogenesis. When administered by gavage, β-myrcene increased the occurrences of hepatocellular carcinoma and hepatoblastoma in male mice, incidences of hepatocellular adenoma or carcinoma in female mice, and incidences of renal tubule adenoma or carcinoma in male rats, and induced rare renal tubule adenomas in female rats. β-Myrcene is not genotoxic. As a component in essential oils used in aromatherapy, β-myrcene does not represent a level of fetotoxicity that would cause any problem. β-Myrcene may cause skin (H315) or eye irritation (H319), however.

Germacrone showed anti-inflammatory, antiandrogenic, and antimicrobial activities. Germacrone from C. aeruginosa has been shown to increase skin penetration of minoxidil. Germacrone exhibited antiproliferative activity against human breast-cancer cell lines (MCF-7 and MDA-MB-231) in a dose-dependent manner, as well as human glioblastoma cell lines (U-87 and U-251) and human hepatoma cells via inducing cell-cycle arrest and apoptosis. Germacrone from C. aromatica EO possessed antitumor effects through a similar mechanism. Germacrone from zedoary EO exhibited strong antioxidant activity and was able to relieve the oxidative stress induced by hydrogen peroxide in mouse neuroblastoma (NG108-15) cells. It inhibited the carrageenin-induced edema in rats, as well as acetic acid-induced vascular permeability and writhing symptoms in mice. Additionally, germacrone effectively inhibited the growth of Pseudomonas aeruginosa (MIC = 15.6μg/mL). Germacrone may cause skin (H315) or eye irritation (H319).

Xanthorrhizol has antioxidant, anti-inflammatory, antitumoral, hepatoprotective, neuroprotective, nephroprotective, estrogenic, and antibacterial properties. Pretreatment with xanthorrhizol (p.o., 200 mg/kg/day for 4 days), significantly reduced the cisplatin-induced nephrotoxicity in mice. Xanthorrhizol showed cancer chemopreventive action via potently inhibiting both COX-2 (IC50 = 0.2 µg/mL) and iNOS (IC50 = 1.0 µg/mL). Xanthorrhizol was antiproliferative to MCF-7 (EC50 = 1.71 µg/mL) and HepG2 cells (IC50 = 4.17 µg/mL) through inducing apoptosis. Xanthorrhizol (at 50 mg/kg) was active against sarcoma 180 ascites in mice. Intraperitoneal administration of xanthorrhizol (0.1, 0.2, 0.5, and 1.0 mg/kg for 2 weeks) inhibited the formation of lung-tumor nodules in mice by 36%, 63%, 61%, and 52%, respectively. Xanthorrhizol strongly inhibited copper-mediated oxidation of human LDL (IC50= 0.4 ± 0.1 µg/mL). Although the toxicological properties have not been thoroughly investigated, xanthorrhizol may cause skin or eye irritation and may damage fertility or the unborn fetus (H360).

β-Elemene inhibited the proliferation of several cancer cell lines. It was cytotoxic to HL-60 cells (IC50= 27.5 µg/mL), K-562 (IC50 = 81 µg/mL) cells, peripheral blood leukocytes (IC50 = 254.3 µg/mL), and human laryngeal-cancer cells in vitro and in vivo in a dose-dependent manner via inducing apoptosis. β-Elemene selectively inhibited the growth of human non-small-cell lung-cancer cells and human ovarian-cancer cells. Moreover, it was able to overcome the cisplatin-resistance developed in cancer cells. β-Elemene showed strong antiangionenic effects. At doses of 20 and 50 mg/kg/day for 21 days, it suppressed VEGF expression in B16F10 melanoma cells in mice, and repressed VEGF-dependent tumor angiogenesis. When used in vitro at 20 and 50 mM, β-elemene inhibited the VEGF-induced sprouting of rat aortic-ring vessels in chick embryo chorioallantoic membranes. β-Elemene protected against carbon tetrachloride-induced liver fibrosis in rats through downregulating the expression of plasma endotoxin, serum TNF-α, and hepatic cluster of differentiation 14 (CD14). β-Elemene (i.p., 50 and 100 mg/kg) reduced angiogenesis in gastric-cancer stem-like cells. In vivo experiments showed that β-elemene treatment suppressed the growth of brain, lung, breast, colon, cervix, and prostate cancers (IC50 = 47–95 µg/mL). In a clinical trial, β-elemene was effective in managing malignant pleural and peritoneal effusions with local pain, fever, and gastrointestional disturbance as the major adverse effects. In another clinical trial that included 40 brain-cancer cases, β-elemene treatment reduced average tumor size by 61%, and four cases completely recovered. No toxicity or dermal data were found for β-elemene; however, its antiangiogenic action might suggest caution in pregnancy.

Terpinolene showed potent DPPH-scavenging activity and remarkable protection against LDL oxidation. Terpinolene was chemoprotective against the in vitro formation of the carcinogen N-nitrosodimethylamine (NDMA) by 79% inhibition. It was neither irritating nor sensitizing when tested at 20% on volunteers. Terpinolene was the reason behind several cases of tea tree oil allergenicity. Terpinolene was sensitizing to all of 16 dermatitis patients sensitive to tea tree oil when tested at 10%. The acute oral LD50 of terpinolene was 4.4 mL/kg in rats and mice. The skin-sensitization thresholds of terpinolene are not known, but the limited data available suggests minimal toxicity.

8,9-Dehydro-9-formyl-cycloisolongifolene showed a good DPPH radical-scavenging activity. It was reported to inhibit Akt/NF-κB signaling pathways in H1299 cells. Curcumol induced apoptosis in human lung adenocarcinoma ASTC-a-1 cells. Curzerene showed excellent antioxidant and anticancer activities. β-Sesquiphellandrene demonstrated remarkable DPPH-scavenging activity. It showed anticancer potential when compared with curcumin and was cytotoxic to the mouse lymphocytic leukemia (L1210) cell line. ar-Curcumene appears to be responsible for the antitumor effects of C. zanthorrhiza. α-Phellandrene possesses antioxidant, antinociceptive, and anti-inflammatory effects.

References 307

  1. 1.

    Ravindran P.N., Babu K.N., Shiva K.N. Botany and crop improvement of tumeric. Turmeric The Genus Curcuma. 2007;15-70.

    Not in our library

  2. 2.
    Chemical profiling and antimicrobial activity of essential oil from Curcuma aeruginosa Roxb., Curcuma glans K. Larsen & J. Mood and Curcuma cf. xanthorrhiza Roxb. collected in Thailand · 2017
    Not checked
  3. 3.

    Leong-Skornikova J., Newman M. Gingers of Cambodia, Laos & Vietnam. 2015.

    Not in our library

  4. 4.

    Chuakul W., Boonpleng A. Ethnomedical uses of Thai Zingiberaceous plant (1). Thai. J. Phytopharm. 2003;10:33-39.

    Not in our library

  5. 5.

    Basaka S., Sarma G.C., Rangan L. Ethnomedical uses of Zingiberaceous plants of Northeast India. J. Ethnopharmacol. 2010;132:286-296.

    Not in our library10.1016/j.jep.2010.08.032

  6. 6.

    Jayaprakasha G.K., Jagan L., Rao M., Sakariah K.K. Chemistry and biological activity of Curcuma longa. Trend Food Sci. Technol. 2005;16:533-548.

    Not in our library10.1016/j.tifs.2005.08.006

  7. 7.

    Mau J., Lai E.Y.C., Wang N.P., Chen C.C., Chang C.H., Chyau C.C. Composition and antioxidant activity of the essential oil from Curcuma zedoaria. Food Chem. 2003;82:583-591.

    Not in our library10.1016/s0308-8146(03)00014-1

  8. 8.

    Lobo R., Prabhu K.S., Shirwaikar A. Curcuma zedoaria Rosc (white turmeric): A review of its chemical, pharmacological and ethnomedicinal properties. J. Pharm. Pharmacol. 2009;61:13-21.

    Not in our library10.1211/jpp.61.01.0003

  9. 9.

    Itokawa H., Shi Q., Akiyama T., Morris-Natschke S.L., Lee K.H. Recent advances in the investigation of curcuminoids. Chin. Med. 2008;11:3.

    Not in our library10.1186/1749-8546-3-11

  10. 10.

    Sikha A., Harini A., Prakash H. Pharmacological activities of wild turmeric (Curcuma aromatica Salisb): A review. J. Pharmacogn. Phytochem. 2015;3:1-4.

    Not in our library

  11. 11.

    Afzal A., Oriqat G., Khan M.A., Jose J., Afzal M. Chemistry and biochemistry of terpenoids from Curcuma and related species. J. Biol. Act. Prod. Nat. 2013;3:1-55.

    Not in our library

  12. 12.

    Krup V., Prakash H.L., Harini A. Pharmacological activities of turmeric (Curcuma longa Linn): A review. J. Tradit. Med. Clin. Naturop. 2013;2:133.

    Not in our library10.4172/2167-1206.1000133

  13. 13.
    Comparative GC-MS analysis of all Curcuma species grown in Sri Lanka by multivariate test · 2017
    Not checked
  14. 14.

    Chen I.N., Chang C.C., Ng C.C., Wang C.Y., Shyu Y.T., Chang T.L. Antioxidant and antimicrobial activity of Zingiberaceae plants in Taiwan. Plants Food Hum. Nutr. 2008;63:15-20.

    Not in our library10.1007/s11130-007-0063-7

  15. 15.

    Reanmongkol W., Subhadhirasakul S., Khaisombat N., Fuengnawakit P., Jantasila S., Khamjun A. Investigation the antinociceptive, antipyretic and anti-inflammatory activities of Curcuma aeruginosa Roxb. extracts in experimental animals. Songklanakarin J. Sci. Technol. 2006;28:999-1008.

    Not in our library

  16. 16.

    Wilson B., Abraham G., Manju V.S., Mathew M., Vimala B., Sundaresan S., Nambisan B. Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. J. Ethnopharmacol. 2005;99:147-151.

    Not in our library10.1016/j.jep.2005.02.004

  17. 17.

    Angel G.R., Menon N., Vimala B., Nambisan B. Essential oil composition of eight starchy Curcuma species. Ind. Crops Prod. 2014;60:233-238.

    Not in our library10.1016/j.indcrop.2014.06.028

  18. 18.

    Sacchetti G., Maielti S., Muzzoli M., Scaglianti M., Manfredini S., Radice M., Bruni R. Comparative evaluation of 11 essential oils of different origin as functional antioxidants, antiradicals and antimicrobials in foods. Food Chem. 2005;91:621-632.

    Not in our library10.1016/j.foodchem.2004.06.031

  19. 19.

    Raut J.S., Karuppayil S.M. A status review on the medicinal properties of essential oils. Ind. Crops Prod. 2014;62:250-264.

    Not in our library10.1016/j.indcrop.2014.05.055

  20. 20.

    Weiss E.A. Spice Crops. 2002.

    Not in our library

  21. 21.

    Gopalan B., Goto M., Kodama A., Hirose T. Supercritical carbon dioxide extraction of turmeric (Curcuma longa). J. Agric. Food Chem. 2000;48:2189-2192.

    Not in our library10.1021/jf9908594

  22. 22.

    Jayaprakasha G.K., Negi P.S., Anandharamakrishnan C., Sakariah K.K. Chemical composition of turmeric oil—A byproduct from turmeric oleoresin industry and its inhibitory activity against different fungi. Z. Naturforsch. Sect. C J. Biosci. 2001;56:40-44.

    Not in our library10.1515/znc-2001-1-207

  23. 23.

    Singh G., Kapoor I.P.S., Singh P., De Heluani C.S., De Lampasona M.P., Catalan C.A.N. Comparative study of chemical composition and antioxidant activity of fresh and dry rhizomes of turmeric (Curcuma longa Linn.). Food Chem. Toxicol. 2010;48:1026-1031.

    Not in our library10.1016/j.fct.2010.01.015

  24. 24.

    Dosoky N.S. Isolation and Identification of Bioactive Compounds from Conradina canescens Gray. Ph.D. Dissertation. 2015.

    Not in our library

  25. 25.

    Sanghamitra N., Sujata M., Nagar K. Differential effect of soil and environment on metabolic expression of turmeric (Curcuma longa cv. Roma). Indian J. Exp. Biol. 2015;53:406-411.

    Not in our library

  26. 26.

    Srinivasan V., Thankamani C.K., Dinesh R., Kandiannan K., Zachariah T.J., Leela N.K., Hamza S., Shajina O., Ansha O. Nutrient management systems in turmeric: Effects on soil quality, rhizome yield and quality. Ind. Crops Prod. 2016;85:241-250.

    Not in our library10.1016/j.indcrop.2016.03.027

  27. 27.

    Burt S. Essential oils: Their antibacterial properties and potential applications in foods—A review. Int. J. Food Microbiol. 2004;94:223-253.

    Not in our library10.1016/j.ijfoodmicro.2004.03.022

  28. 28.

    Kamazeri T.S.A.T., Samah O.A., Taher M., Susanti D., Qaralleh H. Antimicrobial activity and essential oils of Curcuma aeruginosa, Curcuma mangga, and Zingiber cassumunar from Malaysia. Asian Pac. J. Trop. Med. 2012;5:202-209.

    Not in our library10.1016/s1995-7645(12)60025-x

  29. 29.

    Theanphong O., Mingvanish W., Kirdmanee C. Chemical constituents and biological activities of essential oil from Curcuma aeruginosa Roxb. rhizome. Bull. Heal. Sci. Technol. 2015;13:6-16.

    Not in our library

  30. 30.

    Srivilai J., Waranuch N., Tangsumranjit A., Khorana N., Ingkaninan K. Germacrone and sesquiterpene-enriched extracts from Curcuma aeruginosa Roxb. increase skin penetration of minoxidil, a hair growth promoter. Drug Deliv. Transl. Res. 2018;8:140-149.

    Not in our library10.1007/s13346-017-0447-7

  31. 31.

    Jantan I.B., Ahmad A.S., Ali N.A.M., Ahmad A.R., Ibrahim H. Chemical composition of the rhizome oils of four Curcuma species from Malaysia. J. Essent. Oil Res. 1999;11:719-723.

    Not in our library10.1080/10412905.1999.9712004

  32. 32.

    Sirat M.H., Jamil S., Hussain J. Essential oil of Curcuma aeruginosa Roxb. from Malaysia. J. Essent. Oil Res. 1998;10:453-458.

    Not in our library10.1080/10412905.1998.9700942

  33. 33.
    Chemical profiling of Curcuma aeruginosa Roxb. rhizome using different techniques of solvent extraction · 2015
    Not checked
  34. 34.

    Jirovetz L., Buchbauer G., Puschmann C., Shafi M.P., Geetha Nambiar M.K. Essential oil analysis of Curcuma aeruginosa Roxb. leaves from South India. J. Essent. Oil Res. 2000;12:47-49.

    Not in our library10.1080/10412905.2000.9712039

  35. 35.

    Dũng N.X., Tuyêt N.T.B., Leclercq P.A. Characterization of the leaf oil of Curcuma aeruginosa Roxb. from Vietnam. J. Essent. Oil Res. 1995;7:657-659.

    Not in our library10.1080/10412905.1995.9700522

  36. 36.

    Theanphong O. Chemical constituents and antioxidant activities of essential oils from roots and rhizomes of Curcuma alismatifolia Gagnap. from Thailand. J. Appl. Sci. 2017;16:105-111.

    Not in our library10.14416/j.appsci.2017.10.s16

  37. 37.

    Singh G., Singh O.P., Maurya S. Chemical and biocidal investigations on essential oils of some Indian Curcuma species. Prog. Cryst. Growth Charact. Mater. 2002;45:75-81.

    Not in our library10.1016/s0960-8974(02)00030-x

  38. 38.

    Padalia R.C., Verma R.S., Sundaresan V., Chauhan A., Chanotiya C.S., Yadav A. Volatile terpenoid compositions of leaf and rhizome of Curcuma amada Roxb. from northern India. J. Essent. Oil Res. 2013;25:17-22.

    Not in our library10.1080/10412905.2012.747271

  39. 39.

    Choudhury S.N., Rabha L.C., Kanjilal P.B., Ghosh A.C., Leclercq P.A. Essential oil of Curcuma amada Roxb. from northeastern India. J. Essent. Oil Res. 1996;8:79-80.

    Not in our library10.1080/10412905.1996.9700560

  40. 40.

    Mustafa A., Ali M., Khan N.Z. Volatile oil constituents of the fresh rhizomes of Curcuma amada Roxb. J. Essent. Oil Res. 2005;17:490-491.

    Not in our library10.1080/10412905.2005.9698974

  41. 41.

    Rao A.S., Rajanikanth B., Seshadri R. Volatile aroma components of Curcuma amada Roxb. J. Agric. Food Chem. 1989;37:740-743.

    Not in our library10.1021/jf00087a036

  42. 42.

    Srivastava A.K., Srivastava S.K., Shah N.C. Constituents of the rhizome essential oil of Curcuma amada Roxb. from India. J. Essent. Oil Res. 2001;13:63-64.

    Not in our library10.1080/10412905.2001.9699608

  43. 43.

    Srivastava S., Chitranshi N., Srivastava S., Dan M., Rawat A.K.S., Pushpangadan P. Pharmacognostic evaluation of Curcuma aeruginosa Roxb. Nat. Prod. Sci. 2006;12:162-165.

    Not in our library

  44. 44.

    Thongkhwan P., Chaibunga T., Kwanboonjan H., Theanphong O. Essential oil constituents of the fresh root and rhizome of Curcuma angustifolia Roxb. from Thailand. Bull. Heal. Sci. Technol. 2017;15:52-53.

    Not in our library

  45. 45.

    Jena S., Ray A., Banerjee A., Sahoo A., Nasim N., Sahoo S., Kar B., Patnaik J., Panda P.C., Nayak S. Chemical composition and antioxidant activity of essential oil from leaves and rhizomes of Curcuma angustifolia Roxb. Nat. Prod. Res. 2017;31:2188-2191.

    Not in our library10.1080/14786419.2017.1278600

  46. 46.

    Bordoloi A.K., Sperkova J., Leclercq P.A. Essential oils of Curcuma aromatica Salisb. from northeast India. J. Essent. Oil Res. 1999;11:537-540.

    Not in our library10.1080/10412905.1999.9701209

  47. 47.

    Xiang H., Zhang L., Yang Z., Chen F., Zheng X., Liu X. Chemical compositions, antioxidative, antimicrobial, anti-inflammatory and antitumor activities of Curcuma aromatica Salisb. essential oils. Ind. Crops Prod. 2017;108:6-16.

    Not in our library10.1016/j.indcrop.2017.05.058

  48. 48.

    Choudhury S.N., Ghosh A.C., Saikia M., Choudhury M., Leclercq P.A. Volatile constituents of the aerial and underground parts of Curcuma aromatica Salisb from India. J. Essent. Oil Res. 1996;8:633-638.

    Not in our library10.1080/10412905.1996.9701031

  49. 49.

    Xiang H., Zhang L., Xi L., Yang Y., Wang X., Lei D., Zheng X., Liu X. Phytochemical profiles and bioactivities of essential oils extracted from seven Curcuma herbs. Ind. Crops Prod. 2018;111:298-305.

    Not in our library10.1016/j.indcrop.2017.10.035

  50. 50.

    Tsai S.Y., Huang S.J., Chyau C.C., Tsai C.H., Weng C.C., Mau J.L. Composition and antioxidant properties of essential oils from Curcuma rhizome. Asian J. Arts Sci. 2011;2:57-66.

    Not in our library

  51. 51.

    Nampoothiri S.V., Philip R.M., Kankangi S., Kiran C.R., Menon A.N. Essential oil composition, α-amylase inhibition and antiglycation potential of Curcuma aromatica Salisb. J. Essent. Oil Bear. Plants. 2015;18:1051-1058.

    Not in our library10.1080/0972060x.2014.908746

  52. 52.

    Choochote W., Chaiyasit D., Kanjanapothi D., Rattanachanpichai E., Jitpakdi A., Tuetun B., Pitasawat B. Chemical composition and anti-mosquito potential of rhizome extract and volatile oil derived from Curcuma aromatica against Aedes aegypti (Diptera: Culicidae). J. Vector. Ecol. 2005;30:302-309.

    Not in our library

  53. 53.

    Cao J., Qi M., Zhang Y., Zhou S., Shao Q., Fu R. Analysis of volatile compounds in Curcuma wenyujin Y.H. Chen et C. Ling by headspace solvent microextraction-gas chromatography-mass spectrometry. Anal. Chim. Acta. 2006;561:88-95.

    Not in our library10.1016/j.aca.2006.01.040

  54. 54.

    Al-Reza S.M., Rahman A., Sattar M.A., Rahman M.O., Fida H.M. Essential oil composition and antioxidant activities of Curcuma aromatica Salisb. Food Chem. Toxicol. 2010;48:1757-1760.

    Not in our library10.1016/j.fct.2010.04.008

  55. 55.

    Rameshkumar K.B., Sheeja D.B.A., Nair M.S., George V. Curcuma ecalcarata—New natural source of pinocembrin and piperitenone. Nat. Prod. Res. 2015;29:1276-1279.

    Not in our library10.1080/14786419.2014.994210

  56. 56.

    Liu Z.L., Zhao N.N., Liu C.M., Zhou L., Du S.S. Identification of insecticidal constituents of the essential oil of Curcuma wenyujin rhizomes active against Liposcelis bostrychophila Badonnel. Molecules. 2012;17:12049-12060.

    Not in our library10.3390/molecules171012049

  57. 57.

    Pandey A.K., Chowdhury A.R. Volatile constituents of the rhizome oil of Curcuma caesia Roxb. from central India. Flavor Fragr. J. 2003;18:463-465.

    Not in our library10.1002/ffj.1255

  58. 58.

    Behura S., Srivastava V.K. Essential oils of leaves of Curcuma species. J. Essent. Oil Res. 2004;16:109-110.

    Not in our library10.1080/10412905.2004.9698664

  59. 59.

    Raj G., Baby S., Dan M., Thaha A.R.M., Sethuraman M.G., George V. Volatile constituents from the rhizomes of Curcuma haritha Mangaly and Sabu from southern India. Flavour Fragr. J. 2008;23:348-352.

    Not in our library10.1002/ffj.1891

  60. 60.

    Dũng N., Truong P.X., Ky P.T., Leclercq P.A. Volatile constituents of the leaf, stem, rhizome, root and flower oils of Curcuma harmandii Gagnep. from Vietnam. J. Essent. Oil Res. 1997;9:677-681.

    Not in our library10.1080/10412905.1997.9700810

  61. 61.

    Malek S.N., Seng C.K., Zakaria Z., Ali N.A., Ibrahim H., Jalil M.N. The essential oil of Curcuma inodora aff. Blatter from Malaysia. J. Essent. Oil Res. 2006;18:281-283.

    Not in our library10.1080/10412905.2006.9699088

  62. 62.

    Zeng J.H., Xu G.B., Chen X. Application of the chromatographic fingerprint for quality control of essential oil from GuangXi Curcuma kwangsiensis. Med. Chem. Res. 2009;18:158-165.

    Not in our library10.1007/s00044-008-9115-2

  63. 63.

    Zhang L., Yang Z., Huang Z., Zhao M., Li P., Zhou W., Zhang K., Zheng X., Lin L., Tang J., et al. Variation in essential oil and bioactive compounds of Curcuma kwangsiensis collected from natural habitats. Chem. Biodivers. 2017;14:2017.

    Not in our library10.1002/cbdv.201700020

  64. 64.

    Naveen Kumar K., Venkataramana M., Allen J.A., Chandranayaka S., Murali H.S., Batra H.V. Role of Curcuma longa L. essential oil in controlling the growth and zearalenone production of Fusarium graminearum. LWT-Food Sci. Technol. 2016;69:522-528.

    Not in our library10.1016/j.lwt.2016.02.005

  65. 65.

    Chatterjee S., Variyar P.S., Gholap A.S., Bongirwar D.R. Effect of γ-irradiation on the volatile oil constituents of turmeric (Curcuma longa). Food Res. Int. 2000;33:103-106.

    Not in our library10.1016/s0963-9969(00)00012-0

  66. 66.

    Awasthi P.K., Dixit S.C. Chemical composition of Curcuma longa leaves and rhizome oil from the plains of northern India. J. Young Pharm. 2009;1:312-316.

    Not in our library10.4103/0975-1483.59319

  67. 67.

    Kutti Gounder D., Lingamallu J. Comparison of chemical composition and antioxidant potential of volatile oil from fresh, dried and cured turmeric (Curcuma longa) rhizomes. Ind. Crops Prod. 2012;38:124-131.

    Not in our library10.1016/j.indcrop.2012.01.014

  68. 68.

    Raina V.K., Syamsundar S.K. Srivastava, K.V. Rhizome and leaf oil composition of Curcuma longa from the lower Himalayan region of northern India. J. Essent. Oil Res. 2005;17:556-559.

    Not in our library10.1080/10412905.2005.9698993

  69. 69.

    Singh G., Maurya S., Catalan C.A.N., De Lampasona M.P. Chemical, antifungal, insecticidal and antioxidant studies on Curcuma longa essential oil and its oleoresin. Indian Perfum. 2005;49:441-451.

    Not in our library

  70. 70.

    Leela N.K., Tava A., Shafi P.M., John S.P., Chempakami B. Chemical Composition of essential oils of turmeric (Curcuma longa L.). Acta Pharm. 2002;52:137-141.

    Not in our library

  71. 71.

    Jantan I., Saputri F.C., Qaisar M.N., Buang F. Correlation between chemical composition of Curcuma domestica and Curcuma xanthorrhiza and their antioxidant effect on human low-density lipoprotein oxidation. Evid. Based Complement. Altern. Med. 2012;2012:438356.

    Not in our library10.1155/2012/438356

  72. 72.

    Naz S., Ilyas S., Parveen Z., Javed S. Chemical analysis of essential oils from turmeric (Curcuma longa) rhizome through GC-MS. Asian J. Chem. 2010;22:3153-3158.

    Not in our library

  73. 73.

    Naz S., Ilyas S., Jabeen S., Parveen Z. Composition and antibacterial activity of the essential oil from the rhizome of turmeric (Curcuma longa L.). Asian J. Chem. 2011;23:1639-1642.

    Not in our library

  74. 74.

    Zhang L., Yang Z., Chen F., Su P., Chen D., Pan W., Fang Y., Dong C., Zheng X., Du Z. Composition and bioactivity assessment of essential oils of Curcuma longa L. collected in China. Ind. Crops Prod. 2017;109:60-73.

    Not in our library10.1016/j.indcrop.2017.08.009

  75. 75.

    Ling J., Wei B., Lv G., Ji H., Li S. Anti-hyperlipidaemic and antioxidant effects of turmeric oil in hyperlipidaemic rats. Food Chem. 2012;130:229-235.

    Not in our library10.1016/j.foodchem.2011.07.039

  76. 76.

    Ferreira F.D., Kemmelmeier C., Arrotéia C.C., Da Costa C.L., Mallmann C.A., Janeiro V., Ferreira F.M.D., Mossini S.A.G., Silva E.L., Machinski M. Inhibitory effect of the essential oil of Curcuma longa L. and curcumin on aflatoxin production by Aspergillus flavus Link. Food Chem. 2013;136:789-793.

    Not in our library10.1016/j.foodchem.2012.08.003

  77. 77.

    Avanço G.B., Ferreira F.D., Bomfim N.S., Andréia de Souza Rodrigues dos Santos P., Peralta R.M., Brugnari T., Mallmann C.A., de Abreu Filho B.A., Mikcha J.M.G., Machinski M. Curcuma longa L. essential oil composition, antioxidant effect, and effect on Fusarium verticillioides and fumonisin production. Food Control. 2017;73:806-813.

    Not in our library10.1016/j.foodcont.2016.09.032

  78. 78.

    Braga M.E.M., Leal P.F., Carvalho J.E., Meireles M.A.A. Comparison of yield, composition and antioxidant activity of turmeric (Curcuma longa L.) extracts obtained using various techniques. J. Agric. Food Chem. 2003;51:6604-6611.

    Not in our library10.1021/jf0345550

  79. 79.

    Asghari G., Mostajeran A., Shebli M. Curcuminoid and essential oil components of turmeric at different stages of growth cultivated in Iran. Res. Pharm. Sci. 2009;4:55-61.

    Not in our library

  80. 80.

    Marongiu B., Porcedda S., Caredda A., Gioannis B.D., Piras A. Supercritical CO2 extraction of curcumin and essential oil from the rhizomes of turmeric (Curcuma longa L.). J. Essent. Oil Bear. Plants. 2002;5:144-153.

    Not in our library

  81. 81.

    Oyemitan I.A., Elusiyan C.A., Onifade A.O., Akanmu M.A., Oyedeji A.O., McDonald A.G. Neuropharmacological profile and chemical analysis of fresh rhizome essential oil of Curcuma longa (turmeric) cultivated in southwest Nigeria. Toxicol. Rep. 2017;4:391-398.

    Not in our library10.1016/j.toxrep.2017.07.001

  82. 82.

    Gardini F., Belletti N., Ndagijimana M., Guerzoni M.E., Tchoumbougnang F., Zollo P.H.A., Micci C., Lanciotti R., Kamdem S.L.S. Composition of four essential oils obtained from plants from Cameroon, and their bactericidal and bacteriostatic activity against Listeria monocytogenes, Salmonella enteritidis and Staphylococcus aureus. Afr. J. Microbiol. Res. 2009;3:264-271.

    Not in our library

  83. 83.

    Sharma R.K., Mishra B.P., Sharma T.C., Bordloi A.K., Pathak M.G., Leclercq P.A. Essential oil of Curcuma longa L. from Bhutan. J. Essent. Oil Res. 1997;9:589-592.

    Not in our library10.1080/10412905.1997.9700783

  84. 84.

    Chane-Ming J., Vera R., Chalchat J.-C., Cabassu P. Chemical composition of essential oils from rhizomes, leaves and flowers of Curcuma longa L. from Reunion Island. J. Essent. Oil Res. 2002;14:249-251.

    Not in our library10.1080/10412905.2002.9699843

  85. 85.

    Usman L.A., Hamid A.A., George O.C., Ameen O.M., Muhammad N.O., Zubair M.F., Lawal A. Chemical composition of rhizome essential oil of Curcuma longa L. growing in north central Nigeria. World J. Chem. 2009;4:178-181.

    Not in our library

  86. 86.

    Raina V.K., Srivastava S.K., Jain N., Ahmad A., Syamasundar K.V., Aggarwal K.K. Essential oil composition of Curcuma longa L. cv. Roma from the plains of northern India. Flavour Fragr. J. 2002;17:99-102.

    Not in our library10.1002/ffj.1053

  87. 87.

    Martins A.P., Salgueiro L., Gonçalves M.J., Da Cunha A.P., Vila R., Canigueral S., Mazzoni V., Tomi F., Casanova J. Essential oil composition and antimicrobial activity of three zingiberaceae from S. Tomé e Principe. Planta Med. 2001;67:580-584.

    Not in our library10.1055/s-2001-16494

  88. 88.

    Sirat H.M., Jamil S., Rahman A.A. Rhizome oil of Curcuma ochrorhiza Val. J. Essent. Oil Res. 1997;9:351-353.

    Not in our library10.1080/10412905.1997.10554259

  89. 89.

    Sindhu S., Chempakam B., Leela N.K., Suseela Bhai R. Chemoprevention by essential oil of turmeric leaves (Curcuma longa L.) on the growth of Aspergillus flavus and aflatoxin production. Food Chem. Toxicol. 2011;49:1188-1192.

    Not in our library10.1016/j.fct.2011.02.014

  90. 90.

    Garg S.N., Mengi N., Patra N.K., Charles R., Kumar S. Chemical examination of the leaf essential oil of Curcuma longa L. from the north Indian plains. Flavour Fragr. J. 2002;17:103-104.

    Not in our library10.1002/ffj.1056

  91. 91.

    Oguntimein B.O., Weyerstahl P., Marschall-Weyerstahl H. Essential oil of Curcuma longa L. leaves. Flavour Fragr. J. 1990;5:80-90.

    Not in our library10.1002/ffj.2730050206

  92. 92.

    Priya R., Prathapan A., Raghu K.G., Nirmala Menon A. Chemical composition and in vitro antioxidative potential of essential oil isolated from Curcuma longa L. leaves. Asian Pac. J. Trop. Biomed. 2012;2:S695-S699.

    Not in our library10.1016/s2221-1691(12)60298-6

  93. 93.

    Pande C., Chanotiya C.S. Constituents of the leaf oil of Curcuma longa L. from Uttaranchal. J. Essent. Oil Res. 2006;18:166-167.

    Not in our library10.1080/10412905.2006.9699056

  94. 94.

    Essien E., Newby J., Walker T., Setzer W., Ekundayo O. Chemotaxonomic characterization and in-vitro antimicrobial and cytotoxic activities of the leaf essential oil of Curcuma longa grown in southern Nigeria. Medicines. 2015;2:340-349.

    Not in our library10.3390/medicines2040340

  95. 95.

    Zaibunnisa A.H., Norashikin S., Mamot S., Osman H. An experimental design approach for the extraction of volatile compounds from turmeric leaves (Curcuma domestica) using pressurised liquid extraction (PLE). LWT-Food Sci. Technol. 2009;42:233-238.

    Not in our library10.1016/j.lwt.2008.03.015

  96. 96.

    Saccol E.M.H., Londero É.P., Bressan C.A., Salbego J., Gressler L.T., Silva L.V.F., Mourão R.H.V., Oliveira R.B., Llesuy S.F., Baldisserotto B., et al. Oxidative and biochemical responses in Brycon amazonicus anesthetized and sedated with Myrcia sylvatica (G. Mey.) DC. and Curcuma longa L. essential oils. Vet. Anaesth. Analg. 2017;44:555-566.

    Not in our library10.1016/j.vaa.2016.08.005

  97. 97.

    Dũng N.X., Tuyecirct N.T.B., Leclercq P.A. Constituents of the leaf oil of Curcuma domestica L. from Vietnam. J. Essent. Oil Res. 1995;7:701-703.

    Not in our library10.1080/10412905.1995.9700537

  98. 98.

    Wahab I.R., Blagojević P.D., Radulović N.S., Boylan F. Volatiles of Curcuma mangga Val. & Zijp (Zingiberaceae) from Malaysia. Chem. Biodivers. 2011;8:2005-2014.

    Not in our library10.1002/cbdv.201100135

  99. 99.

    Wong K.C., Chong T.C., Chee S.G. Essential oil of Curcumma mangga Val. and Van Zijp. rhizome. J. Essent. Oil Res. 1999;11:349-351.

    Not in our library10.1080/10412905.1999.9701151

  100. 100.

    Zhang L., Yang Z., Wei J., Su P., Pan W., Zheng X., Zhang K., Lin L., Tang J., Fang Y., et al. Essential oil composition and bioactivity variation in wild-growing populations of Curcuma phaeocaulis Valeton collected from China. Ind. Crops Prod. 2017;103:274-282.

    Not in our library10.1016/j.indcrop.2017.04.019

  101. 101.

    Dũng N.X., Tuyêt N.T.B., Van Khlên P., Barthel A., Leclercq P.A. Chemical composition of the flower oil of Curcuma pierreana Gagnep. from Vietnam. J. Essent. Oil Res. 1998;10:527-528.

    Not in our library10.1080/10412905.1998.9700960

  102. 102.

    Muniyappan N., Nagarajan N.S. Green synthesis of gold nanoparticles using Curcuma pseudomontana essential oil, its biological activity and cytotoxicity against human ductal breast carcinoma cells T47D. J. Environ. Chem. Eng. 2014;2:2037-2044.

    Not in our library10.1016/j.jece.2014.03.004

  103. 103.

    Hong S.L., Lee G.S., Syed Abdul Rahman S.N., Ahmed Hamdi O.A., Awang K., Aznam Nugroho N., Abd Malek S.N. Essential oil content of the rhizome of Curcuma purpurascens Bl. (Temu Tis) and its antiproliferative effect on selected human carcinoma cell lines. Sci. World J. 2014;2014.

    Not in our library10.1155/2014/397430

  104. 104.

    Theanphong O., Jenjittikul T., Mingvanish W. The rhizome oil of Curcuma rhabdota Sirirugsa & M.F. Newman from Thailand. Plant Science: International Proceedings. 2015;146-150.

    Not in our library

  105. 105.

    Zhou X., Li Z., Liang G., Zhu J., Wang D., Cai Z. Analysis of volatile components of Curcuma sichuanensis X. X. Chen by gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2007;43:440-444.

    Not in our library10.1016/j.jpba.2006.07.024

  106. 106.

    Cuong N.M., Ha V.T., Khanh P.N., Van D.T., Cuong T.D., Huong T.T., Thuy D.T.T., Nhan N.T., Hanh N.P., Toan T.Q., et al. Chemical compositions and antimicrobial activity of essential oil from the rhizomes of Curcuma singularis growing in Vietnam. Am. J. Essent. Oils Nat. Prod. 2017;5:20-25.

    Not in our library

  107. 107.

    Ky P.T., Van De Ven L.J.M., Leclercq P.A., Dũng N.X. Volatile constituents of the essential oil of Curcuma trichosantha Gagnep. from Vietnam. J. Essent. Oil Res. 1994;6:213-214.

    Not in our library

  108. 108.

    Yasni S., Imaizumi K., Sin K., Sugano M., Nonaka G. Sidik Identification of an active principle in essential oils and hexane-soluble fractions of Curcuma xanthorrhiza Roxb. showing triglyceride-lowering action in rats. Food Chem. Toxicol. 1994;32:273-278.

    Not in our library10.1016/0278-6915(94)90200-3

  109. 109.

    Zhou L., Zhang K., Li J., Cui X., Wang A., Huang S., Zheng S., Lu Y., Chen W. Inhibition of vascular endothelial growth factor-mediated angiogenesis involved in reproductive toxicity induced by sesquiterpenoids of Curcuma zedoaria in rats. Reprod. Toxicol. 2013;37:62-69.

    Not in our library10.1016/j.reprotox.2013.02.001

  110. 110.

    Lai E.Y.C., Chyau C.-C., Mau J.-L., Chen C.-C., Lai Y.-J., Shih C.-F., Lin L.-L. Antimicrobial activity and cytotoxicity of the essential oil of Curcuma zedoaria. Am. J. Chin. Med. 2004;32:281-290.

    Not in our library10.1142/s0192415x0400193x

  111. 111.

    Singh P., Singh S., Kapoor I.P.S., Singh G., Isidorov V., Szczepaniak L. Chemical composition and antioxidant activities of essential oil and oleoresins from Curcuma zedoaria rhizomes, part-74. Food Biosci. 2013;3:42-48.

    Not in our library10.1016/j.fbio.2013.06.002

  112. 112.

    Purkayastha J., Nath S.C., Klinkby N. Essential oil of the rhizome of Curcuma zedoaria (Christm.) Rosc. native to northeast India. J. Essent. Oil Res. 2006;18:154-155.

    Not in our library10.1080/10412905.2006.9699050

  113. 113.

    Jarikasem S., Thubthimthed S., Chawananoraseth K., Suntorntanasat T. Essential oils from three Curcuma species collected in Thailand. Acta Hortic. 2005;677:37-41.

    Not in our library10.17660/actahortic.2005.675.4

  114. 114.

    Shi H., Tan B., Ji G., Lu L., Cao A., Shi S., Xie J. Zedoary oil (Ezhu You) inhibits proliferation of AGS cells. Chin. Med. 2013;8:13.

    Not in our library10.1186/1749-8546-8-13

  115. 115.

    Garg S.N., Naquvi A.A., Bansal R.P., Bahl J.R., Kumar S. Chemical composition of the essential oil from the leaves of Curcuma zedoaria Rosc. of Indian origin. J. Essent. Oil Res. 2005;17:29-31.

    Not in our library10.1080/10412905.2005.9698821

  116. 116.

    Dahal K.R., Idris S., De Guzman C.C., Siemonsma J.S. Plant Resources of South-East Asia No 13. Spices. 1999;111-116.

    Not in our library

  117. 117.

    Zachariah T.J., Babu K.N. Effect of storage of fresh turmeric rhizome on oleoresin and curcumin contents. J. Spice Arom. Crop. 1992;1:55-58.

    Not in our library

  118. 118.

    Jayashree E., John Zachariah T. Processing of turmeric (Curcuma longa) by different curing methods and its effect on quality. Indian J. Agric. Sci. 2016;86:696-698.

    Not in our library

  119. 119.

    Govindarajan V.S. Turmeric-Chemistry, technology and quality. CRC Crit. Rev. Food Sci. Nutr. 1980;12:199-301.

    Not in our library10.1080/10408398009527278

  120. 120.

    Helen C.F., Su R.H., Ghulam J. Isolation, purification and characterization of insect repellents from Curcuma longa L. J. Agric. Food Chem. 1982;30:290-292.

    Not in our library

  121. 121.

    Srimal R.C. Turmeric: A brief review of medicinal properties. Fitoterapia. 1997;68:483-493.

    Not in our library

  122. 122.

    Narayana D.B.A., Brindavanam N.B., Dobriyal R.M., Katuyar K.C. Indian spices: An overview with special reference to neutraceuticals. J. Med. Aromat. Plant Sci. 2000;22:236-246.

    Not in our library

  123. 123.

    Paranjpe P. Herbs for Beauty. 2001.

    Not in our library

  124. 124.

    Chempakam B., Parthasarathy V.A., Parthasarathy V.A., Chempakam B., Zachariah T.J. Chemistry of Spices. 2008;97-123.

    Not in our library

  125. 125.

    Tisserand R., Young R. Essential Oil Safety. 2014.

    Not in our library

  126. 126.

    Balakrishnan K.V., Ravindra P.N., Nirmal Babu K., Sivaraman K. Post harvest technology and processing of turmeric. Turmeric, The Genus Curcuma. 2007;Volume 45:193-256.

    Not in our library

  127. 127.

    Parveen Z., Nawaz S., Siddique S., Shahzad K. Composition and antimicrobial activity of the essential oil from leaves of Curcuma longa L. Kasur variety. Indian J. Pharm. Sci. 2013;75:117-122.

    Not in our library10.4103/0250-474x.113544

  128. 128.

    Bansal R.P., Bahl J.R., Garg S.N., Naqvi A.A., Sushil K., Kumar S. Differential chemical composition of the essential oils of the shoot organs, rhizomes and rhizoids in the turmeric Curcuma longa grown in Indo-Gangetic plains. Pharm. Biol. 2002;40:384-389.

    Not in our library10.1076/phbi.40.5.384.8458

  129. 129.

    Pitasawat B., Champakaew D., Choochote W., Jitpakdi A., Chaithong U., Kanjanapothi D., Rattanachanpichai E., Tippawangkosol P., Riyong D., Tuetun B., et al. Aromatic plant-derived essential oil: An alternative larvicide for mosquito control. Fitoterapia. 2007;78:205-210.

    Not in our library10.1016/j.fitote.2007.01.003

  130. 130.

    Seo W.G., Hwang J.C., Kang S.K., Jin U.H., Suh S.J., Moon S.K., Kim C.H. Suppressive effect of Zedoariae rhizome on pulmonary metastasis of B16 melanoma cells. J. Ethnopharmacol. 2005;101:249-257.

    Not in our library10.1016/j.jep.2005.04.037

  131. 131.

    Makabe H., Maru N., Kuwabara A., Kamo T., Hirota M. Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat. Prod. Res. 2006;20:680-685.

    Not in our library10.1080/14786410500462900

  132. 132.

    Navarro Dde F., De Souza M.M., Neto R.A., Golin V., Niero R., Yunes R.A., Delle Monache F., Filho V.C. Phytochemical analysis and analgesic properties of Curcuma zedoaria grown in Brazil. Phytomedicine. 2002;9:427-432.

    Not in our library10.1078/09447110260571670

  133. 133.

    Matsuda H., Tewtrakul S., Morikawa T., Nakamura A., Yoshikawa M. Anti-allergic principles from Thai zedoary: Structural requirements of curcuminoids for inhibition of degranulation and effect on the release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg. Med. Chem. 2004;12:5891-5898.

    Not in our library10.1016/j.bmc.2004.08.027

  134. 134.

    Ansari M.H., Ahmad S. Screening of some medicinal plants for antiamoebic action. Fitoterapia. 1991;62:171-175.

    Not in our library

  135. 135.

    Thaina P., Tungcharoena P., Wongnawaa M., Reanmongkol W., Subhadhirasakul S. Uterine relaxant effects of Curcuma aeruginosa Roxb. rhizome extracts. J. Ethnopharmacol. 2009;121:433-443.

    Not in our library10.1016/j.jep.2008.10.022

  136. 136.

    Sookchot T. Chemotaxonomy of Medicinal and Auspicious Plants in Zingiberaceae Sold at Ban Thum, Chiang Dao District, Chiang Mai Province. Master’s Thesis. 2005.

    Not in our library

  137. 137.

    Suphrom N., Pumthong G., Khorana N., Waranuch N., Limpeanchob N., Ingkaninan K. Anti-androgenic effect of sesquiterpenoids isolated from the rhizomes of Curcuma aeruginosa Roxb. Fitoterapia. 2012;83:864-871.

    Not in our library10.1016/j.fitote.2012.03.017

  138. 138.

    Nanda Y., Singson N., Rao A.N. Ethnomedicinal plants of Thadou tribe of Manipur (India)-1. Pleione. 2013;7:138-145.

    Not in our library

  139. 139.

    Neamsuvan O., Tuwaemaengae T., Bensulong F., Asae A., Mosamae K. A survey of folk remedies for gastrointestinal tract diseases from Thailand’s three southern border provinces. J. Ethnopharmacol. 2012;144:11-21.

    Not in our library10.1016/j.jep.2012.07.043

  140. 140.

    Choudhury D., Ghosal M., Das A.P., Mandal P. Development of single node cutting propagation techniques and evaluation of antioxidant activities of Curcuma aeruginosa Roxburgh rhizome. Int. J. Pharm. Pharm. Sci. 2013;5:227-234.

    Not in our library

  141. 141.

    Salleh N.M., Ismail S., Ab Halim M. Effects of Curcuma xanthorrhiza extracts and their constituents on phase II drug-metabolizing enzymes activity. Pharmacognosy Res. 2016;8:309.

    Not in our library10.4103/0974-8490.188873

  142. 142.

    Hsu H.Y., Chen Y.P., Shen S.J., Hsu C.S., Chen C.C., Chang H.C. Oriental Materia Medica, A Concise Guide. 1986.

    Not in our library

  143. 143.

    Perry M.L. Medicinal Plants of East and South East Asia, Attributed Properties and Uses. 1980.

    Not in our library

  144. 144.

    Mary H.P.A., Susheela G.K., Jayasree S., Nizzy A.M., Rajagopal B., Jeeva S. Phytochemical characterization and antimicrobial activity of Curcuma xanthorrhiza Roxb. Asian Pac. J. Trop. Biomed. 2012;2:S637-S640.

    Not in our library10.1016/s2221-1691(12)60288-3

  145. 145.

    Salea R., Widjojokusumo E., Veriansyah B., Tjandrawinata R.R. Optimizing oil and xanthorrhizol extraction from Curcuma xanthorrhiza Roxb. rhizome by supercritical carbon dioxide. J. Food Sci. Technol. 2014;51:2197-2203.

    Not in our library10.1007/s13197-014-1272-3

  146. 146.

    Sukari M.A.H., Saad S.M., Lajis N.H., Rahman M., Muse R., Yusuf U.K., Riyanto S. Chemical constituents and bioactivity of Curcuma aeruginosa Roxb. Nat. Prod. Sci. 2007;13:175-179.

    Not in our library

  147. 147.

    Li S.Y., Li S.P. Antioxidant activities of essential oil of Curcuma longa and Curcuma wenyujin. Int. J. Essent. Oil Ther. 2009;3:31-34.

    Not in our library

  148. 148.

    Shi J.H., Li C.Z., Liu D.L. Experimental research on the pharmacology of Curcuma aromatica volatile oil. Zhongyao Tongbao. 1981;6:36-38.

    Not in our library

  149. 149.

    Chadha Y.R. The Wealth of India. A Dictionary of Indian Raw Materials and Industrial Products. 2001.

    Not in our library

  150. 150.

    Chopra R.N., Nayar S.L., Chopra I.C. Glossary of Indian Medicinal Plants. 1956.

    Not in our library

  151. 151.

    Kim J.K., Jo C., Hwang H.J., Park H.J., Kim Y.J., Byun M.W. Color improvement by irradiation of Curcuma aromatica extract for industrial application. Radiat. Phys. Chem. 2006;75:449-452.

    Not in our library10.1016/j.radphyschem.2005.10.019

  152. 152.

    Mao Q.Q., Zhen H., Zhong X.M., Feng C.R., Pan A.J., Li Z.Y., Ip S.P., Che C.T. Effects of SYJN, a Chinese herbal formula, on chronic unpredictable stress-induced changes in behavior and brain BDNF in rats. J. Ethnopharmacol. 2010;128:336-341.

    Not in our library10.1016/j.jep.2010.01.050

  153. 153.

    Wang L.Y., Zhang M., Zhang C.F., Wang Z.T. Diaryl derivatives from the root tuber of Curcuma longa. Biochem. Syst. Ecol. 2008;36:476-480.

    Not in our library10.1016/j.bse.2007.12.005

  154. 154.

    Wu D.L. Zingiberaceae Resource of China. 2015.

    Not in our library

  155. 155.

    Alonso-Amelot M.E. Multitargeted bioactive materials of plants in the Curcuma genus and related compounds: Recent advances. Studi. Nat. Prod. Chem. 2016;47:111-200.

    Not in our library

  156. 156.

    Varadarajan R., Mathew M.C.R., Souprayan S. Hepatoprotective efficacy of ethanolic extracts of rhizome Curcuma amada Roxb. in experimental rats. Ann. Plant Sci. 2018;71:1966-1972.

    Not in our library10.21746/aps.2018.7.1.9

  157. 157.

    Policegoudra R.S., Aradhya S.M., Singh L. Mango ginger (Curcuma amada Roxb.)—A promising spice for phytochemicals and biological activities. J. Biosci. 2011;36:739-748.

    Not in our library10.1007/s12038-011-9106-1

  158. 158.

    Mohanta P.K., Rout S.D., Sahu H.K. Ethnomedicinal plant resources of Similipal Biosphere Reserve, Orissa, India. Zoo’s Print J. 2006;21:2372-2374.

    Not in our library10.11609/jott.zpj.1435.2372-4

  159. 159.

    Kunwar R.M., Shrestha K.P., Bussmann R.W. Traditional herbal medicine in far-west Nepal: A pharmacological appraisal. J. Ethnobiol. Ethnomed. 2010;6:1-18.

    Not in our library10.1186/1746-4269-6-35

  160. 160.

    Rokaya M.B., Munzbergova Z., Timsina B. Ethnobotanical study of medicinal plants from the Humla district of western Nepal. J. Ethnopharmacol. 2010;130:485-504.

    Not in our library10.1016/j.jep.2010.05.036

  161. 161.

    Devi L.R., Rana V.S., Devi S.I., Verdeguer M., Blázquez M.A. Chemical composition and antimicrobial activity of the essential oil of Curcuma leucorhiza Roxb. J. Essent. Oil Res. 2012;24:533-538.

    Not in our library10.1080/10412905.2012.728089

  162. 162.

    Lakshmi S., Padmaja G., Remani P. Antitumour effects of isocurcumenol isolated from Curcuma zedoaria rhizomes on human and murine cancer cells. Int. J. Med. Chem. 2011;1-13.

    Not in our library10.1155/2011/253962

  163. 163.

    Singh V., Jain M., Misra A., Khanna V., Rana M., Prakash P., Malasoni R., Dwivedi A.K., Dikshit M., Barthwal M.K. Curcuma oil ameliorates hyperlipidaemia and associated deleterious effects in golden Syrian hamsters. Br. J. Nutr. 2013;110:437-446.

    Not in our library10.1017/s0007114512005363

  164. 164.

    Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., Sashida Y., Takahashi K., Kawada T., Nakagawa K., et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 2005;53:959-963.

    Not in our library10.1021/jf0483873

  165. 165.

    Honda S., Aoki F., Tanaka H., Kishida H., Nishiyama T., Okada S., Matsumoto I., Abe K., Mae T. Effects of ingested turmeric oleoresin on glucose and lipid metabolisms in obese diabetic mice: A DNA microarray study. J. Agric. Food Chem. 2006;54:9055-9062.

    Not in our library10.1021/jf061788t

  166. 166.

    Omosa L.K., Midiwo J.O., Kuete V. Curcuma longa. 2012.

    Not in our library

  167. 167.

    Lekshmi P.C., Arimboor R., Indulekha P.S., Menon A.N. Turmeric (Curcuma longa L.) volatile oil inhibits key enzymes linked to type 2 diabetes. Int. J. Food Sci. Nutr. 2012;63:832-834.

    Not in our library10.3109/09637486.2011.607156

  168. 168.

    Zhao J., Zhang J.S., Yang B., Lv G.P., Li S.P. Free radical scavenging activity and characterization of sesquiterpenoids in four species of Curcuma using a TLC bioautography assay and GC–MS analysis. Molecules. 2010;15:7547-7557.

    Not in our library10.3390/molecules15117547

  169. 169.

    Himaja M., Ranjitha A., Ramana M.V., Anand M., Karigar A. Phytochemical screening and antioxidant activity of rhizome part Curcuma zedoaria. Int. J. Res. Ayurveda Pharm. 2010;1:414-417.

    Not in our library

  170. 170.

    Dohare P., Garg P., Sharma U., Jagannathan N.R., Ray M. Neuroprotective efficacy and therapeutic window of Curcuma oil: In rat embolic stroke model. BMC Complement. Altern. Med. 2008;8.

    Not in our library10.1186/1472-6882-8-55

  171. 171.

    Rathore P., Dohare P., Varma S., Ray A., Sharma U., Jaganathanan N.R., Ray M. Curcuma oil: Reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem. Res. 2008;33:1672-1682.

    Not in our library10.1007/s11064-007-9515-6

  172. 172.

    Manhas A., Khanna V., Prakash P., Goyal D., Malasoni R., Naqvi A., Dwivedi A.K., Dikshit M., Jagavelu K. Curcuma oil reduces endothelial cell-mediated inflammation in postmyocardial ischemia/reperfusion in rats. J. Cardiovasc. Pharmacol. 2014;64:228-236.

    Not in our library10.1097/fjc.0000000000000110

  173. 173.

    Prakash P., Misra A., Surin W.R., Jain M., Bhatta R.S., Pal R., Raj K., Barthwal M.K., Dikshit M. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb. Res. 2011;127:111-118.

    Not in our library10.1016/j.thromres.2010.11.007

  174. 174.

    Lee H.S. Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresour. Technol. 2006;97:1372-1376.

    Not in our library10.1016/j.biortech.2005.07.006

  175. 175.

    Jacob J.N. Comparative studies in relation to the structure and biochemical properties of the active compounds in the volatile and nonvolatile rractions of turmeric (C. longa) and ginger (Z. officinale). Stud. Nat. Prod. Chem. 2016;48:101-135.

    Not in our library

  176. 176.

    Arora R., Basu N., Kapoor V., Jain A. Anti-inflammatory studies on Curcuma longa (turmeric). Indian J. Med. Res. 1971;59:1289-1295.

    Not in our library

  177. 177.

    Manosroi J., Dhumtanom P., Manosroi A. Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett. 2006;235:114-120.

    Not in our library10.1016/j.canlet.2005.04.021

  178. 178.

    Jayaprakasha G.K., Jena B.S., Negi P.S., Sakariah K.K. Evaluation of antioxidant activities and antimutagenicity of turmeric oil: A byproduct from curcumin production. Z. Naturforsch. 2002;57:828-835.

    Not in our library10.1515/znc-2002-9-1013

  179. 179.

    Hastak K., Lubri N., Jakhi S.D., More C., John A., Ghaisas S.D., Bhide S.V. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett. 1997;116:265-269.

    Not in our library10.1016/s0304-3835(97)00205-x

  180. 180.

    Joshi J., Ghaisas S., Vaidya A., Vaidya R., Kamat D.V., Bhagwat A.N., Bhide S. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J. Assoc. Physicians India. 2003;51:1055-1060.

    Not in our library

  181. 181.

    Lantz R.C., Chen G.J., Solyom A.M., Jolad S.D., Timmermann B.N. The effect of turmeric extracts on inflammatory mediator production. Phytomedicine. 2005;12:445-452.

    Not in our library10.1016/j.phymed.2003.12.011

  182. 182.

    Funk J.L., Frye J.B., Oyarzo J.N., Zhang H., Barbara N. Anti-arthritic effects and toxicity of the essential oils of turmeric (Curcuma longa L.). J. Agric. Food Chem. 2010;58:842-849.

    Not in our library10.1021/jf9027206

  183. 183.

    Kiso Y., Suzuki Y., Watarable N. Antihepatotoxic principles of Curcuma longa rhizomes. Planta Med. 1983;49:185-187.

    Not in our library10.1055/s-2007-969845

  184. 184.

    Singh V., Rana M., Jain M., Singh N., Naqvi A., Malasoni R., Dwivedi A.K., Dikshit M., Barthwal M.K. Curcuma oil attenuates accelerated atherosclerosis and macrophage foam-cell formation by modulating genes involved in plaque stability, lipid homeostasis and inflammation. Br. J. Nutr. 2015;113:100-113.

    Not in our library10.1017/s0007114514003195

  185. 185.

    Shafreen R.B., Lubinska M., Różańska A., Dymerski T., Namieśnik J., Katrich E., Gorinstein S. Human serum interactions with phenolic and aroma substances of Kaffir (Citrus hystrix) and Key lime (Citrus aurantifolia) juices. J. Lumin. 2018.

    Not in our library10.1016/j.jlumin.2018.04.010

  186. 186.

    Nwozo S.O., Osunmadewa D.A., Oyinloye B.E. Anti-fatty liver effects of oils from Zingiber officinale and Curcuma longa on ethanol-induced fatty liver in rats. J. Integr. Med. 2014;12:59-65.

    Not in our library10.1016/s2095-4964(14)60006-6

  187. 187.

    Palasa K., Scsikaran B., Krishna T.P., Krishnaswamy K. Effect of turmeric on urinary mutagens in smokers. Mutagenesis. 1992;7:107-109.

    Not in our library10.1093/mutage/7.2.107

  188. 188.

    Ferreira L.A.F., Henriques O.B., Andreoni A.A.S., Vital G.R.F., Campos M.M.C., Habermehl G.G., De Moraes V.L.G. Antivenom and biological effects of ar-turmerone isolated from Curcuma longa (Zingiberaceae). Toxicon. 1992;30:1211-1218.

    Not in our library10.1016/0041-0101(92)90437-a

  189. 189.

    Fagodia S.K., Singh H.P., Batish D.R., Kohli R.K. Phytotoxicity and cytotoxicity of Citrus aurantiifolia essential oil and its major constituents: Limonene and citral. Ind. Crops Prod. 2017;108:708-715.

    Not in our library10.1016/j.indcrop.2017.07.005

  190. 190.

    Negi P.S., Jayaprakasha G.K., Jagan Mohan Rao L., Sakariah K.K. Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J. Agric. Food Chem. 1999;47:4297-4300.

    Not in our library10.1021/jf990308d

  191. 191.

    Behura C., Ray P., Rathi C.C., Mishra R.K., Ramachandraiah O.S., Charyulu J.K. Antifungal activity of essential oil of Curcuma longa against five rice pathogens in vitro. J. Essent. Oil Bear. Plants. 2000;3:79-84.

    Not in our library

  192. 192.

    Apisariyakul A., Vanittanakom N., Buddhasukh D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J. Ethnopharmacol. 1995;49:163-169.

    Not in our library10.1016/0378-8741(95)01320-2

  193. 193.

    Fouad H.A., Da Camara C.A.G. Chemical composition and bioactivity of peel oils from Citrus aurantiifolia and Citrus reticulata and enantiomers of their major constituent against Sitophilus zeamais (Coleoptera: Curculionidae). J. Stored Prod. Res. 2017;73:30-36.

    Not in our library10.1016/j.jspr.2017.06.001

  194. 194.

    Roth G.N., Chandra A., Nair M.G. Novel bioactivities of Curcuma longa constituents. J. Nat. Prod. 1998;61:542-545.

    Not in our library10.1021/np970459f

  195. 195.

    Tawatsin A., Wratten S.D., Scott R.R., Thavara U., Techadamrongsin Y. Repellency of volatile oils from plants against three mosquito vectors. J. Vector Ecol. 2001;26:76-82.

    Not in our library

  196. 196.

    Sumathi S., Iswariya G.T., Sivaprabha B., Dharani B., Radha P., Padma P.R. Comparative study of radical scavenging activity and phytochemical analysis of fresh and dry rhizomes of Curcuma zedoaria. Int. J. Pharm. Sci. Res. 2013;4:1069-1073.

    Not in our library

  197. 197.

    Angel G.R., Vimala B., Bala N. Antioxidant and antimicrobial activity of essential oils from nine starchy Curcuma species. Int. J. Curr. Pharm. Res. 2012;4:45-47.

    Not in our library

  198. 198.

    Myoungae K. Cytotoxic activity of the extracts from Curcuma zedoaria. J. Toxicol. Environ. Health. 2003;19:293-296.

    Not in our library

  199. 199.

    Chen C., Chen Y., Hsi Y.T., Chang C.S., Huang L.F., Ho C.T., Way T.D., Kao J.Y. Chemical constituents and anticancer activity of Curcuma zedoaria Roscoe essential oil against non-small cell lung carcinoma cells in vitro and in vivo. J. Agric. Food Chem. 2013;61:11418-11427.

    Not in our library10.1021/jf4026184

  200. 200.

    Chen W., Lu Y., Gao M., Wu J., Wang A., Shi R. Anti-angiogenesis effect of essential oil from Curcuma zedoaria in vitro and in vivo. J. Ethnopharmacol. 2011;133:220-226.

    Not in our library10.1016/j.jep.2010.09.031

  201. 201.

    Cheng J.H., Chang G., Wu W.Y. A controlled clinical study between hepatic arterial infusion with embolized Curcuma aromatic oil and chemical drugs in treating primary liver cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;21:165-167.

    Not in our library

  202. 202.

    Zhou Y., Shen J., Xia L., Wang Y. Curcuma zedoaria (Berg.) Rosc. essential oil and paclitaxel synergistically enhance the apoptosis of SKOV3 cells. Mol. Med. Rep. 2015;12:1253-1257.

    Not in our library10.3892/mmr.2015.3473

  203. 203.

    Wu W.Y., Luo Y.J., Cheng J.H. Zedoary turmeric oil inhibits transplantal hepatoma in rat via hepatic artery perfusion. World Chin. J. Dig. 1998;11:260-263.

    Not in our library10.11569/wcjd.v11.i3.260

  204. 204.

    Handajani J., Narissi D.H. The effects of Curcuma zedoaria oil on high blood sugar level and gingivitis. Dent. J. 2015;69:69-73.

    Not in our library10.20473/j.djmkg.v48.i2.p69-73

  205. 205.

    Pumthong G., Asawanonda P., Varothai S., Jariyasethavong V., Triwongwaranat D., Suthipinittharm P., Ingkaninan K., Leelapornpisit P., Waranuch N. Curcuma aeruginosa, a novel botanically derived 5-α-reductase inhibitor in the treatment of male-pattern baldness: A multicenter, randomized, double-blind, placebo-controlled study. J. Dermatolog. Treat. 2012;23:385-392.

    Not in our library10.3109/09546634.2011.568470

  206. 206.

    Srivilai J., Phimnuan P., Jaisabai J., Luangtoomma N., Waranuch N., Khorana N., Wisuitiprot W., Scholfield C.N., Champachaisri K., Ingkaninan K. Curcuma aeruginosa Roxb. essential oil slows hair-growth and lightens skin in axillae; a randomised, double blinded trial. Phytomedicine. 2017;25:29-38.

    Not in our library10.1016/j.phymed.2016.12.007

  207. 207.

    Wahyuni W.T., Batubara I., Tambunan D.Y. Antibacterial and teeth biofilm degradation activity of Curcuma aeruginosa essential oil. J. Biol. Sci. 2017;17:84-90.

    Not in our library10.3923/jbs.2017.84.90

  208. 208.

    Ma J.W., Tsao T.C., His Y.T., Lin Y.C., Chen Y., Chen Y., Ho C.T., Kao J.Y., Way T.D. Essential oil of Curcuma aromatica induces apoptosis in human non-small-cell lung carcinoma cells. J. Funct. Foods. 2016;30:101-112.

    Not in our library10.1016/j.jff.2016.01.019

  209. 209.

    Li Y., Wo J.M., Liu Q., Li X., Martin R.C. Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Ann. Surg. Oncol. 2009;16:515-523.

    Not in our library10.1245/s10434-008-0228-0

  210. 210.

    Tao L., Zhou L., Zheng L., Yao M. Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother. Pharmacol. 2006;58:24-34.

    Not in our library10.1007/s00280-005-0137-x

  211. 211.

    Wu W.Y., Luo Y.J., Cheng J.H., Chang G., Liu W.S., Li R.X. Therapeutic effect of Curcuma aramatica oil infused via hepatic artery against transplanted hepatoma in rats. Huaren Xiaohua Zazhi. 1998;6:859-861.

    Not in our library

  212. 212.

    Wu W.Y., Xu Q., Shi L.C., Zhang W.B. Inhibitory effects of Curcuma aromatica oil on proliferation of hepatoma in mice. World J. Gastroenterol. 2000;6:216-219.

    Not in our library10.3748/wjg.v6.i2.216

  213. 213.

    Cheng J.H., Wu W.Y., Liu W.S., Chang G., Liu Y.L., Yang Z.G., Li L.N., Zhou H. Treatment of 17 cases of patients with primary liver cancer with Curcuma aromatica oil infused via hepatic artery. Shijie Huaren Xiaohua Zazhi. 1999;7:92.

    Not in our library

  214. 214.

    Li Y., Shi X., Zhang J., Zhang X., Martin R.C.G. Hepatic protection and anticancer activity of Curcuma: A potential chemopreventive strategy against hepatocellular carcinoma. Int. J. Oncol. 2014;44:505-513.

    Not in our library10.3892/ijo.2013.2184

  215. 215.

    Zhao L., Zhang H., Yang Y., Zheng Y., Dong M., Wang Y., Bai G., Ye X., Yan Z., Gao H. Serum metabonomic analysis of protective effects of Curcuma aromatica oil on renal fibrosis rats. PLoS ONE. 2014;9:e108678.

    Not in our library10.1371/journal.pone.0108678

  216. 216.

    Xia Q., Wang X., Xu D.J., Chen X.H., Chen F.H. Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential oil. Thromb. Res. 2012;130:409-414.

    Not in our library10.1016/j.thromres.2012.04.005

  217. 217.

    Al-Reza S.M., Rahman A., Parvin T., Rahman M.M., Rahman M.S. Chemical composition and antibacterial activities of essential oil and organic extracts of Curcuma aromatica Salisb. J. Food Saf. 2011;31:433-438.

    Not in our library10.1111/j.1745-4565.2011.00318.x

  218. 218.

    Li Y., Feng J., Mo Y., Liu H., Yang B. Concordance between cardio-protective effect on isoproterenol-induced acute myocardial ischemia and phenolic content of different extracts of Curcuma aromatica. Pharm. Biol. 2016;54:3226-3231.

    Not in our library10.1080/13880209.2016.1216134

  219. 219.

    Liu H.H., Wei Y., Cui J., Wang L.H., Liu S.G., Long Z.F. Antifungal activities of the extracts from Curcuma phaeocaulis against Phoma wasabiae. J. Sichuan Univ. (Nat. Sci. Ed.). 2008;45:1235-1238.

    Not in our library

  220. 220.

    Schmidt E., Ryabchenko B., Wanner J., Jäger W., Jirovetz L. Cytotoxic active constituents of essential oils of Curcuma longa and Curcuma zanthorrhiza. Nat. Prod. Commun. 2015;10:139-141.

    Not in our library

  221. 221.

    Ozaki Y. Antiinflammatory effect of Curcuma xanthorrhiza Roxb and its active principles. Chem. Pharm. Bull. 1990;38:1045-1048.

    Not in our library10.1248/cpb.38.1045

  222. 222.

    Wicaksono A.J., Yuniarti N., Pramono S. Analgesic effect of combination of essential oil Curcuma xanthorriza Roxb. and its curcuminoids in mice. Trad. Med. J. 2015;20:16-23.

    Not in our library

  223. 223.

    Yasni S., Imaizumi K., Sugano M. Effects of an Indonesian medicinal plant, Curcuma xanthorrhiza Roxb. on the levels of serum glucose and triglyceride, fatty acid desaturation, and bile acid excretion in streptozotocin-induced diabetic rats. Agric. Biol. Chem. 1991;55:3005-3010.

    Not in our library10.1271/bbb1961.55.3005

  224. 224.

    Yasni S., Imaizumi K., Nakamura M., Aimoto J., Sugano M. Effects of Curcuma xanthorrhiza Roxb. and curcuminoids on the level of serum and liver lipids, serum apolipoprotein A-I and lipogenic enzymes in rats. Food Chem. Toxicol. 1993;31:213-218.

    Not in our library10.1016/0278-6915(93)90096-h

  225. 225.

    Ramachandran C., Quirin K.W., Escalon E.A., Lollett I.V., Melnick S.J. Therapeutic effect of supercritical CO2 extracts of Curcuma species with cancer drugs in rhabdomyosarcoma cell lines. Phytother. Res. 2015;29:1152-1160.

    Not in our library10.1002/ptr.5360

  226. 226.

    Ramachandran C., Lollett I.V., Escalon E., Quirin K.W., Melnick S.J. Anticancer potential and mechanism of action of mango ginger (Curcuma amada Roxb.) supercritical CO2 extract in human glioblastoma cells. J. Evid. Based Complement. Altern. Med. 2015;20:109-119.

    Not in our library10.1177/2156587214563731

  227. 227.

    Ramachandran C., Portalatin G.M., Prado A.M., Quirin K.W., Escalon E., Melnick S.J. In vivo antitumor effect of supercritical CO2 extract of mango ginger (Curcuma amada Roxb) in U-87MG human glioblastoma nude mice xenografts. J. Evid. Based Complement. Altern. Med. 2017;22:260-267.

    Not in our library10.1177/2156587216659390

  228. 228.

    Kumar A., Singh L., Chomwal R., Sawal R. Anti-microbial potential of the rhizome extracts of Curcuma amada Roxb. J. Pharm. Res. 2009;2:339-340.

    Not in our library

  229. 229.

    George M., Britto S.J., Arulappan M.T., Marandi R.R., Kindo I., Dessy V.J. Phytochemical, antioxidant and antibacterial studies on the essential oil of the rhizome of Curcuma amada Roxb. Int. J. Curr. Res. 2015;7:18098-18104.

    Not in our library

  230. 230.

    Singh D., Singh A.K. Repellent and insecticidal properties of essential oils against housefly, Musca domestica L. Int. J. Trop. Insect Sci. 1991;4:487-491.

    Not in our library10.1017/s1742758400011401

  231. 231.

    Dohare P., Garg P., Jain V., Nath C., Ray M. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav. Brain Res. 2008;193:289-297.

    Not in our library10.1016/j.bbr.2008.06.012

  232. 232.

    Li C., Li L., Luo J., Huang N. Effect of turmeric volatile oil on the respiratory tract. Zhongguo Zhong Yao Za Zhi. 1998;23:624-625.

    Not in our library

  233. 233.

    Murakami A., Furukawa I., Miyamoto S., Tanaka T., Ohigashi H. Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis. Biofactors. 2013;39:221-232.

    Not in our library10.1002/biof.1054

  234. 234.

    Xiao Y., Yang F.Q., Li S.P., Hu G., Lee S.M., Wang Y.T. Essential oil of Curcuma wenyujin induces apoptosis in human hepatoma cells. World J. Gastroenterol. 2008;14:4309-4318.

    Not in our library10.3748/wjg.14.4309

  235. 235.

    Su M.Q., Zhou Y.R., Li C.Q., Wang Z., Wang Y.L., Shen B.Y., Dou J. Zedoary Turmeric oil induces senescence and apoptosis in human colon cancer HCT116 cells. Nat. Prod. Commun. 2018;13:907-910.

    Not in our library

  236. 236.

    Wang Y.F., Liu S.Q., Zhao J.H. Observation of therapeutic effect of compound zedoary turmeric oil duppositories for treating monilial vaginitis with pregnancy. Hebei Yi Yao. 2006;28:839-840.

    Not in our library

  237. 237.

    Yang H., Wang X.P., Yu L.L., Zheng S. The antitumor activity of elemene is associated with apoptosis. Zhonghua Zhongliu Zazhi. 1996;18:169-172.

    Not in our library10.1007/bf02974669

  238. 238.

    Jena S., Ray A., Sahoo A., Kar B., Panda P.C., Nayak S. Chemical constituents of leaf essential oil of Curcuma angustifolia Roxb. growing in eastern India. J. Essent. Oil Bear. Plants. 2016;19:1527-1531.

    Not in our library10.1080/0972060x.2016.1250677

  239. 239.

    Opdyke D.L.J. Monographs on fragrance raw materials. Food Cosmet. Toxicol. 1973;11:855-876.

    Not in our library10.1016/s0015-6264(73)80370-0

  240. 240.

    Zhou N.N., Mao X.J., Zhang J., Yang S.W., Zhang J.M. Pharmacological investigation on contraindication of Curcuma zedoaria. Chin. Arch. Tradit. Chin. Med. 2004;22:2291-2294.

    Not in our library

  241. 241.

    Kong Y.C., Xie J.X., But P.P.H. Fertility regulating agents from traditional Chinese medicine. J. Ethnopharmacol. 1986;15:1-44.

    Not in our library10.1016/0378-8741(86)90102-9

  242. 242.

    Oh S., Han A., Park H.R., Jang E.J., Kim H.K., Jeong M.G., Song H., Park G.H., Seo E.K., Hwang E.S. Suppression of inflammatory cytokine production by ar-turmerone isolated from Curcuma phacaulis essential oil. Chem. Biodivers. 2014;11:1034-1041.

    Not in our library10.1002/cbdv.201300397

  243. 243.

    Rana M., Reddy S.S., Maurya P., Singh V., Chaturvedi S., Kaur K., Agarwal H., Ahmad H., Naqvi A., Dwivedi A.K., et al. Turmerone enriched standardized Curcuma longa extract alleviates LPS induced inflammation and cytokine production by regulating TLR4–IRAK1–ROS–MAPK–NFkB axis. J. Funct. Foods. 2015;16:152-163.

    Not in our library10.1016/j.jff.2015.04.034

  244. 244.

    Hucklenbroich J., Klein R., Neumaier B., Graf R., Fink G.R., Schroeter M., Rueger M.A. Aromatic turmerone induces neural stem cell proliferation in vitro and in vivo. Stem Cell Res. Ther. 2014;5:100.

    Not in our library10.1186/scrt500

  245. 245.

    Paek S.H., Kim G.J., Jeong H.S., Yum S.K. Ar-turmerone and β-atlantone induce internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia HL-60 cells. Arch. Pharmacol. Res. 1996;19:91-94.

    Not in our library10.1007/bf02976840

  246. 246.

    Baik K.U., Jung S.H., Ahn B.Z. Recognition of pharmacophore of ar-turmerone for its anticancer activity. Arch. Pharmacol. Res. 1993;16:254-256.

    Not in our library10.1007/bf02974492

  247. 247.

    Ji M., Choi J., Lee J., Lee Y. Induction of apoptosis by ar-turmerone on various cell lines. Int. J. Mol. Med. 2004;14:253-256.

    Not in our library10.3892/ijmm.14.2.253

  248. 248.

    Itokawa H., Hirayama F., Funakoshi K., Takeya K. Studies on the antitumor bisabolane sesquiterpenoids isolated from Curcuma xanthorrhiza. Chem. Pharmacol. Bull. 1985;33:3488-3492.

    Not in our library10.1248/cpb.33.3488

  249. 249.

    Lee S.K., Hong C.H., Huh S.K., Kim S.S., Oh O.J., Min H.Y., Park K.K., Chung W.Y., Hwang J.K. Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells. J. Environ. Pathol. Toxicol. Oncol. 2002;21:141-148.

    Not in our library10.1615/jenvironpatholtoxicoloncol.v21.i2.70

  250. 250.

    Lee H.S. Antimicrobial properties of turmeric (Curcuma longa L.) rhizome-derived ar-turmerone and curcumin. Food Sci. Biotechnol. 2006;15:559-563.

    Not in our library

  251. 251.

    Dhingra O.D., Jham G.N., Barcelos R.C., Mendonça F.A., Ghiviriga I. Isolation and identification of the principal fungitoxic component of turmeric essential oil. J. Essent. Oil Res. 2007;19:387-391.

    Not in our library10.1080/10412905.2007.9699312

  252. 252.

    Li J., Bian W.H., Wan J., Zhou J., Lin Y., Wang J.R., Wang Z.X., Shen Q., Wang K.M. Curdione inhibits proliferation of MCF-7 cells by inducing apoptosis. Asian Pac. J. Cancer Prev. 2014;15:9997-10001.

    Not in our library10.7314/apjcp.2014.15.22.9997

  253. 253.

    Oh O.J., Min H.Y., Lee S.K. Inhibition of inducible prostaglandin E2 production and cyclooxygenase-2 expression by curdione from Curcuma zedoaria. Arch. Pharm. Res. 2007;30:1236-1239.

    Not in our library10.1007/bf02980264

  254. 254.

    Perry N.S., Houghton P.J., Sampson J., Theobald A.E., Hart S., Lis-Balchin M., Hoult J.R., Evans P., Jenner P., Milligan S., et al. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer’s disease. J. Pharm. Pharmacol. 2001;53:1347-1356.

    Not in our library10.1211/0022357011777846

  255. 255.

    Saito Y., Shiga A., Yoshida Y., Furuhashi T., Fujita Y., Niki E. Effects of a novel gaseous antioxidative system containing a rosemary extract on the oxidation induced by nitrogen dioxide and ultraviolet radiation. Biosci. Biotechnol. Biochem. 2004;68:781-786.

    Not in our library10.1271/bbb.68.781

  256. 256.

    Moteki H., Hibasami H., Yamada Y., Katsuzaki H., Imai K., Komiya T. Specific induction of apoptosis by 1,8-cineole in two human leukemia cell lines, but not a in human stomach cancer cell line. Oncol. Rep. 2002;9:757-760.

    Not in our library10.3892/or.9.4.757

  257. 257.

    Lampronti I., Saab A.M., Gambari R. Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division. Int. J. Oncol. 2006;29:989-995.

    Not in our library10.3892/ijo.29.4.989

  258. 258.

    Loizzo M.R., Tundis R., Menichini F., Saab A.M., Statti G.A., Menichini F. Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells. Cell Prolif. 2008;41:1002-1012.

    Not in our library10.1111/j.1365-2184.2008.00561.x

  259. 259.

    Owolabi M.S., Ogundajo A.L., Dosoky N.S., Setzer W.N. The cytotoxic activity of Annona muricata leaf oil from Badagary, Nigeria. Am. J. Essent. Oils Nat. Prod. 2013;1:1-3.

    Not in our library

  260. 260.

    Soares D.C., Portella N.A., Ramos M.F.D.S., Siani A.C., Saraiva E.M. trans-Caryophyllene: An effective antileishmanial compound found in commercial copaiba oil (Copaifera spp.). Evid.-Based Complement. Altern. Med. 2013;2013:1-13.

    Not in our library10.1155/2013/761323

  261. 261.

    Izumi E., Ueda-Nakamura T., Veiga V.F., Pinto A.C., Nakamura C.V. Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity. J. Med. Chem. 2012;55:2994-3001.

    Not in our library10.1021/jm201451h

  262. 262.

    De-Oliveira A.C., Ribeiro-Pinto L.F., Paumgartten J.R. In vitro inhibition of CYP2B1 monooxygenase by β-myrcene and other monoterpenoid compounds. Toxicol. Lett. 1997;92:39-46.

    Not in our library10.1016/s0378-4274(97)00034-9

  263. 263.

    Sawamura M., Sun S.H., Ozaki K., Ishikawa J., Ukeda H. Inhibitory effects of Citrus essential oils and their components on the formation of N-nitrosodimethylamine. J. Agric. Food Chem. 1999;47:4868-4872.

    Not in our library10.1021/jf9903206

  264. 264.

    Chaouki W., Leger D.Y., Liagre B., Beneytout J.L., Hmamouchi M. Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fundam Clin. Pharmacol. 2009;23:549-556.

    Not in our library10.1111/j.1472-8206.2009.00738.x

  265. 265.

    Dosoky N.S., Pokharel S.K., Setzer W.N. Leaf essential oil composition, antimicrobial; and cytotoxic activities of Cleistocalyx operculatus from Hetauda, Nepal. Am. J. Essent. Oils Nat. Prod. 2015;3:34-37.

    Not in our library

  266. 266.

    Mitić-Culafić D., Zegura B., Nikolić B., Vuković-Gacić B., Knezević-Vukcević J., Filipic M. Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells. Food Chem. Toxicol. 2009;47:260-266.

    Not in our library10.1016/j.fct.2008.11.015

  267. 267.

    Hossain C.F., Al-Amin M., Sayem A.S.M., Siragee I.H., Tunan A.M., Hassan F., Kabir M.M., Sultana G.N.N. Antinociceptive principle from Curcuma aeruginosa. BMC Complement. Altern. Med. 2015;15:191.

    Not in our library10.1186/s12906-015-0720-6

  268. 268.

    Zhong Z., Chen X., Tan W., Xu Z., Zhou K., Wu T., Cui L., Wang Y. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur. J. Pharmacol. 2011;667:50-55.

    Not in our library10.1016/j.ejphar.2011.03.041

  269. 269.

    Liu B., Gao Y.Q., Wang X.M., Wang Y.C., Fu L.Q. Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest. Mol. Med. Rep. 2014;10:1046-1050.

    Not in our library10.3892/mmr.2014.2290

  270. 270.

    Liu Y., Wang W., Fang B., Ma F., Zheng Q., Deng P., He G. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur. J. Pharmacol. 2013;698:95-102.

    Not in our library10.1016/j.ejphar.2012.10.013

  271. 271.

    Hamdi O.A.A., Ye L.J., Kamarudin M.N.A., Hazni H., Paydar M., Looi C.Y., Shilpi J.A., Kadir H.A., Awang K. Neuroprotective and antioxidant constituents from Curcuma zedoaria rhizomes. Rec. Nat. Prod. 2015;9:349-355.

    Not in our library

  272. 272.

    Diastuti H., Syah Y.M., Juliawaty L.D., Singgih M. Antibacterial activity of germacrane type sesquiterpenes from Curcuma heyneana rhizomes. Indones. J. Chem. 2014;14:32-34.

    Not in our library10.22146/ijc.21264

  273. 273.

    Kim S.H., Hong K.O., Hwang J.K., Park K.K. Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice. Food Chem. Toxicol. 2005;43:117-122.

    Not in our library10.1016/j.fct.2004.08.018

  274. 274.

    Oon S.F., Nallappan M., Tee T.T., Shohaimi S., Kassim N.K., Sa’ariwijaya M.S.F., Cheah Y.H. Xanthorrhizol: A review of its pharmacological activities and anticancer properties. Cancer Cell Int. 2015;15:100.

    Not in our library10.1186/s12935-015-0255-4

  275. 275.

    Choi M.A., Kim S.H., Chung W.Y., Hwang J.K., Park K.K. Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Biochem. Biophys. Res. Commun. 2005;326:210-217.

    Not in our library10.1016/j.bbrc.2004.11.020

  276. 276.

    Chen W., Lu Y., Wu J., Gao M., Wang A., Xu B. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother. Pharmacol. 2011;67:799-808.

    Not in our library10.1007/s00280-010-1378-x

  277. 277.

    Liu J., Zhang Z., Gao J., Xie J., Yang L., Hu S. Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis. Front. Med. 2011;5:101-105.

    Not in our library10.1007/s11684-011-0111-4

  278. 278.

    Li Q.Q., Wang G., Huang F., Banda M., Reed E. Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J. Pharm. Pharmacol. 2010;62:1018-1027.

    Not in our library10.1111/j.2042-7158.2010.01135.x

  279. 279.

    Tan P., Zhong W., Cai W. Clinical study on treatment of 40 cases of malignant brain tumor by elemene emulsion injection. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000;20:645-648.

    Not in our library

  280. 280.

    Kim H.J., Chen F., Wu C., Wang X., Chung H.Y., Jin Z. Evaluation of antioxidant activity of Australian tea tree (Melaleuca alternifolia) oil and its components. J. Agric. Food Chem. 2004;52:2849-2854.

    Not in our library10.1021/jf035377d

  281. 281.

    Li J., Li F., Xu Y., Yang W., Qu L., Xiang Q., Liu C., Li D. Chemical composition and synergistic antioxidant activities of essential oils from Atractylodes macrocephala and Astragalus membranaceus. Nat. Prod. Commun. 2013;8:1321-1324.

    Not in our library

  282. 282.

    Zhang W., Wang Z., Chen T. Curcumol induces apoptosis via caspases independent mitochondrial pathway in human lung adenocarcinoma ASTC-a-1 cells. Med. Oncol. 2011;28:307-314.

    Not in our library10.1007/s12032-010-9431-5

  283. 283.

    Hsu B. The use of herbs as anticancer agents. Am. J. Chin. Med. 1980;8:301-306.

    Not in our library10.1142/s0192415x80000281

  284. 284.

    Tyagi A.K., Prasad S., Yuan W., Li S., Aggarwal B.B. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: Comparison with curcumin. Investig. New Drugs. 2015;33:1175-1186.

    Not in our library10.1007/s10637-015-0296-5

  285. 285.

    Lima D.F., Brandão M.S., Moura J.B., Leitão J.M.R.S., Carvalho F.A.A., Miúra L.M.C.V. Antinociceptive activity of the monoterpene α-phellandrene in rodents: Possible mechanisms of action. J. Pharm. Pharmacol. 2012;64:283-292.

    Not in our library10.1111/j.2042-7158.2011.01401.x

  286. 286.

    Da Silva J.K.R., Maia J.G.S., Dosoky N.S., Setzer W.N. Antioxidant, antimicrobial, and cytotoxic properties of Aniba parviflora essential oils from the Amazon. Nat. Prod. Commun. 2016;11:1025-1028.

    Not in our library

  287. 287.

    ar-Turmerone.

    Not in our library

  288. 288.

    Ciftci O., Ozdemir I., Tanyildizi S., Yildiz S., Oguzturk H. Antioxidative effects of curcumin, β-myrcene and 1,8-cineole against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in rats liver. Toxicol. Ind. Heal. 2011;27:447-453.

    Not in our library10.1177/0748233710388452

  289. 289.

    Melis K., Janssens G., Bochner A. Accidental nasal eucalyptol and menthol instillation. Acta Clin. Belg. Suppl. 1990;13:101-102.

    Not in our library10.1007/bf00443114

  290. 290.

    Jenner P.M., Hagan E.C., Taylor J.M., Al E. Food flavorings and compounds of related structure I. Acute oral toxicity. Food Cosmet. Toxicol. 1964;2:327-343.

    Not in our library10.1016/s0015-6264(64)80192-9

  291. 291.

    Kubo I., Chaudhuri S.K., Kubo Y., Sanchez Y., Ogura T., Saito T., Ishikawa H., Haraguchi H. Cytotoxic and antioxidative sesquiterpenoids from Heterotheca inuloides. Planta Med. 1996;62:427-430.

    Not in our library10.1055/s-2006-957932

  292. 292.

    Da Silva S.L., Figueiredo P.M., Yano T. Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves. Eur. J. Pharmacol. 2007;576:180-188.

    Not in our library10.1016/j.ejphar.2007.07.065

  293. 293.

    Frosch P.J., Johansen J.D., Menné T., Pirker C., Rastogi S.C., Andersen K.E., Bruze M., Goossens A., Lepoittevin J.P., White I.R. Further important sensitizers in patients sensitive to fragrances. Contact Dermat. 2002;47:279-287.

    Not in our library10.1034/j.1600-0536.2002.470204.x

  294. 294.

    Matura M., Skold M., Borje A., Al E. Selected oxidized fragrance terpenes are common contact allergens. Contact Dermat. 2005;52:320-328.

    Not in our library10.1111/j.0105-1873.2005.00605.x

  295. 295.

    Di Sotto A., Evandri M.G., Mazzanti G. Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay. Mutat. Res. 2008;653:130-133.

    Not in our library10.1016/j.mrgentox.2008.04.004

  296. 296.
    Study of the effects of ß-myrcene on rat fertility and general reproductive performance · 1998
    Not checked
  297. 297.

    National Toxicology Program. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (gavage studies). Natl. Toxicol. Progr. Tech. Rep. Ser. 2010;557:1-163.

    Not in our library

  298. 298.

    Grosse Y., Loomis D., Guyton K.Z., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Mattock H., Straif K. Some chemicals that cause tumours of the urinary tract in rodents. Lancet Oncol. 2017;18:1003-1004.

    Not in our library10.1016/s1470-2045(17)30505-3

  299. 299.

    Beta-Myrcene.

    Not in our library

  300. 300.

    Germacrone.

    Not in our library

  301. 301.

    Xanthorrhizol.

    Not in our library

  302. 302.

    Wang G., Li X., Huang F., Zhao J., Ding H., Cunningham C., Coad J.E., Flynn D.C., Reed E., Li Q.Q. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell. Mol. Life Sci. 2005;62:881-893.

    Not in our library10.1007/s00018-005-5017-3

  303. 303.

    Zou L., Liu W., Yu L. Beta-Elemene induces apoptosis of K562 leukemia cells. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;23:196-198.

    Not in our library

  304. 304.

    Yan B., Zhou Y., Feng S., Lv C., Xiu L., Zhang Y., Shi J., Li Y., Wei P., Qin Z. β-Elemene-attenuated tumor angiogenesis by targeting Notch-1 in gastric cancer stem-like cells. Evid. Based. Complement. Altern. Med. 2013;2013:1-12.

    Not in our library10.1155/2013/268468

  305. 305.

    Opdyke D.L.J. Monographs on fragrance raw materials. Food Cosmet. Toxicol. 1976;14:197-198.

    Not in our library10.1016/s0015-6264(76)80424-5

  306. 306.

    Hausen B.M., Reichling J., Harkenthal M. Degradation products of monoterpenes are the sensitizing agents in tea tree oil. Am. J. Contact Dermat. 1999;10:68-77.

    Not in our library10.1016/s1046-199x(99)90002-7

  307. 307.

    Ahn B.Z., Lee J.H. Cytotoxic and cytotoxicity-potentiating effects of the Curcuma root on L1210 cell. Korean J. Pharmacogn. 1989;20:223-226.

    Not in our library

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.